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ABSTRACT
MECHANISTIC STUDIES OF PROTON GRADIENT-DRIVEN PROTEIN
TRANSLOCATION BY DROPLET-INTERFACE BILAYER TECHNIQUES
MAY 2017
EN-HSIN LEE, B.S., NATIONAL TAIWAN UNIVERISTY
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Matthew A. Holden
Transmembrane proton gradient plays a fundamental role in protein translocation
across cellular membranes, including the transport of secreted enzymes from
bacterial pathogens into host cells. Much attention has been devoted to
understanding the machinery of such delivery and how it functions. Over the past
decade, translocation of anthrax toxin has been widely studied not only because of
its central role in the deadly pathogenesis of Bacillus anthracis, but also because that
it is one of the most tractable toxins and thus serves as an attractive model for
studying the translocation machinery that is dependent on proton gradient across
membrane. Electrophysiological system for studying anthrax toxin translocation on
planar lipid bilayers has yielded invaluable data on the process. However, the
limitations of planar bilayers demand development of other sophisticated platforms
to elucidate the mechanisms. This thesis will describe how droplet-interface bilayer
(DIB) techniques, which have been developed as a model membrane system with
distinct advantages over other platforms, are employed to study proton-gradient
driven translocation of anthrax toxin. Our development of a novel perfusion system
based on DIB allowed the proton gradient to be precisely and repeatedly switched
over time. This system not only allows extensive studies in anthrax translocation
process but is also broadly applicable to a variety of studies in membrane pores.
Using this method, we discovered strong evidence for the current anthrax toxin
translocation model, the conformational change of the toxin accompanied with its
pH environments, and the small molecules that have interactions with the toxin.
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CHAPTER 1
INTRODUCTION

1.1 Anthrax Toxin
A key strategy for pathogenic bacteria survival from the attack of immune
system in host cells is to deliver toxic enzymes that disrupt various metabolic
steps into the cytosol of host cells. There are a variety of mechanisms for the
delivery of these enzymes across the plasma membrane and into the cytosol. 1-4
Much work has been devoted to understanding how pathogenic bacteria damage
their hosts and how toxins might be used in research and medicine. Binary A/B
toxins such as diphtheria, botulinum and anthrax use their own machinery to form
transmembrane pores in order to gain entry into the cytosol and disrupt the
metabolic pathways of host cells, and they are among the most widely studied
membrane transport systems.5 Anthrax toxin6-10 in particular, produced by
Bacillus anthracis, has been an attractive model system for proton gradient-driven
protein translocation for several reasons.9,11-13 First, the three components of
anthrax toxin can be expressed separately by recombinant methods and studied
independently. Therefore, in comparison with other toxins, such as botulinum
toxin, in which the A and B moieties are derived from a single polypeptide chain,
anthrax toxin is far less dangerous to work with. Second, anthrax toxin
translocation can be reconstituted from purified proteins and studied by planar
bilayer electrophysiology, where one can precisely control the membrane
potential and solution conditions in order to determine their effect on
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translocation. Finally, in contrast to the bacterium, Bacillus anthracis, anthrax
toxin itself is not considered a threat to national security as a select agent, which
would impede its use in academic research.
Anthrax toxin is an ensemble of three individually nontoxic multidomain
proteins.7,11,14-16 One of the proteins is the receptor-binding component, called
protective antigen (PA, 83 kDa). The other two are the enzymatic components
named edema factor (EF, 89 kDa) and lethal factor (LF, 90 kDa). The current
knowledge of anthrax toxin assembly and transport is as follows. (Figure 1.1)
Anthrax toxin action begins with the binding of PA to either of two cell-surface
receptors, ANTXR1 (TEM8 or ATR1) or ANTXR2 (CMG2 or ATR2).6,8,17-19 PA is then
activated by a furin-family protease, which cleaves off a 20-kDa piece (PA20) from
its N-terminal side and leaves the remaining 63-kDa portion (PA63) on the
receptor. PA63 subsequently self-assembles into either a heptameric or octameric
ring-shaped oligomer called the pre-pore structure.19-25 Each heptamer or octamer
is capable of binding up to three or four molecules of LF, EF, or both to generate a
pre-pore complex.22,25 (LF and EF may be involved in the PA63 assembly
mechanism as well to produce similar outcomes.16,24,25) The complex is
endocytosed and enters the endosome. Upon acidification of the endosome, PA
pre-pore converts to a pore structure that inserts into the endosomal
membrane21,26,27 and translocates EF and LF into the cytosol. EF and LF
translocation through the cation-selective pore and into the cytosol is driven by
proton motive force (PMF) derived from a transmembrane proton gradient. 28-30
After entering the host cell, LF inhibits cell signaling by cleaving the N-terminus of
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mitogen-activated protein kinase kinases (MKKs), which play a key role in the
regulation of signal transduction pathways that direct cellular responses to a
diverse array of stimuli.31-34 On the other hand, EF is an adenylate cyclase that
greatly increases cAMP concentration in the cell and causes edema.34-36

Figure 1.1 Assembly and entry of anthrax toxin into the host cell.
(Reproduced from Ref. 7.*)

*

Permission is not required from Annual Reviews for reproduction.
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1.1.1 The critical structures of protective antigen
The structures of soluble PA pre-pore and membrane-inserted PA pore
states have been studied previously.11,18,19,21,23-25,37-44 Three critical portions of PA
pore have been revealed to play important roles in translocating LF or EF. (Figure
1.2) Near the top of PA pore, a hydrophobic cleft formed at the interface of
adjacent PA monomers, called α-clamp, binds to the substrate and feeds it into
pore lumen.9,10,25,45 Alpha-clamp binds nonspecifically to helices of the substrate
with various side chain sizes, charges, and polarities. Recently, it has been revealed
that the binding between substrate and the α-clamp facilitates substrate unfolding,
which is required for its translocation.25 About one-third of the distance into PA
pore, a hydrophobic bottleneck constricts the pore, called the φ-clamp.28,39,40,43,46
Phi-clamp is composed of a ring of phenylalanine (Phe) 427 residues from PA
monomers. With the diameter of only 6 Å, studies have shown that φ-clamp acts as
a conductance-blocking site that separates proton concentration and electrical
potential throughout the pore. Mutations to this site lead to defects in
translocation, especially when it is replaced by small or hydrophilic residues. 39
The third portion is the β-barrel stem that comprises the bottom two-thirds of PA
pore.28,30,37,38,47 With alternating patches of positively and negatively charged
residues on its inner surface, the β-barrel stem has been suggested to play an
important role in translocation as the other two clamps. Studies have shown that
when the negative charges near the top of the β-barrel are removed, the cationselectivity of PA pore is diminished and the translocation is defective.30 These
three portions of PA pore bind substrates nonspecifically so that it is able to
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facilitate the unfolding and translocation of the substrate without producing the
tight binding between the translocase and the substrate that impede the
translocation.

Figure 1.2 Critical structures for translocating substrates in a PA pore. Upon
translocation, each unfolded substrate first bind to a α-clamp site, which is the
cleft on top of a PA pore. Subsequently, it threads into the φ-clamp, which is the
narrow bottleneck within the pore. Finally, the substrate encounters the β-barrel
tube that acts as a charge clamp with positively (blue) and negatively (red)
charged patches. (Reproduced from Ref. 10.*)

1.1.2 The pH gradient-driven translocation and the Brownian ratchet model
While the proteolytic activation of PA83 is carried out in vivo by furin-family
proteases, it can be replicated in vitro with trypsin.7,8,12,20,37 When PA63 monomer
is purified from trypsin-activated PA83, it is found to spontaneously selfReproduced from Ref. 10 with permission of John Wiley and Sons. (License Number:
4082630509538)
*
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oligomerize into the heptameric ring-shaped pre-pore structure, which is stable in
solution with pH above 8.7,16,20 This allows the studies of anthrax translocation to
be performed on the model membrane systems without cellular receptors. On the
other hand, although the estimates of magnitude of membrane potential (Δψ) and
the range of pH gradient (ΔpH) across endosomal membrane vary widely, it has
been demonstrated that these two (Δψ and ΔpH) are the driving forces of anthrax
toxin translocation.13,28,29 Therefore, the planar lipid bilayer apparatus, in which
one can easily control Δψ and ΔpH across the membrane, has been an important
model membrane system for studying the mechanisms of anthrax toxin
translocation. (Figure 1.3a) Specifically, the ionic current that passes through the
cation-selective PA pores under different membrane environments in planar lipid
bilayer can be utilized for kinetic analysis of anthrax translocation.28-30,45,48,49
When the pore is blocked by the substrates, the current is reduced. The
restoration of the current after the pore blocking therefore represents the
translocation of the substrates. (Figure 1.3b) This provides a means of monitoring
translocation in real time, by which the translocation activation energy can be
computed from the half-time of each translocation. By altering the membrane
potential or pH environment coupled with site-directed mutagenesis, changes in
translocation activation energy have been studied for understanding the
requirements of the driving forces and how each portion of the proteins
contributes to the translocation. Together with the equilibrium stability studies by
fluorescence equilibrium denaturation or circular dichroism (CD) spectroscopy,
structural-based energetic models of translocation was proposed.28,29 (Figure 1.3c)

6

Figure 1.3 a. Planar lipid bilayer electrophysiology. Two aqueous chambers
(cis and trans) are separated by a small hole, ~50 to 200 μm in diameter, wherein
the membrane is formed. The current passing through the membrane is amplified
and monitored by a voltage-clamp amplifier connected to the electrodes. b.
Typical anthrax translocation performed on planar lipid bilayer. At first, PA
pre-pore is added to the cis chamber at a low Δψ. The substrate (in this case, LFN)
is then added to the same chamber until the current is blocked. This cis chamber is
then perfused of unbound substrates. At time zero, translocation is triggered
either by higher Δψ (this case) or ΔpH (not shown), and the translocation kinetics
can be calculated from the translocation half time t1/2. c. Structural and energetic
models of anthrax translocation. The energy model has two barriers and one
well at the φ-clamp. In short, substrate protein is destabilized by acidic pH
conditions on the cis side so that it can unfold and pass into the φ-clamp. Either a
favorable ΔpH or Δψ can reduce the translocation barrier at trans side.
Translocation barrier (continuous line) can kinetically limit the translocation, but
when this barrier is reduced by large ΔpH or Δψ, the unfolding barrier is ratelimiting (dotted line). (b and c are reproduced from Ref. 28.*)
Reprinted from J. Mol. Biol., 355 (5), Krantz, B. A. et al, Protein Translocation Through the
Anthrax Toxin Transmembrane Pore Is Driven by a Proton Gradient., 968–979, 2006, with
permission from Elsevier. (License Number: 4082630803272)
*
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Base on these studies, a putative Brownian ratchet model of protongradient-powered translocation has been postulated.10,30 (Figure 1.4) In the
Brownian ratchet model, the α-clamp, φ-clamp and β-barrel stem coordinate
together to unfold and translocate substrate under ΔpH environment. At first,
folded substrate and unstructured leader sequence bind and dock to the PA pore.
The α-clamp acts as a helix nucleating binding site, orienting and feeding the
growing helical chain into the pore, where the φ-clamp can impede proton flow
and grip the N-terminal of the peptide when ΔpH rises. Acidic (negatively charged)
substrate residues on the lower pH side (cis side) are then protonated and become
neutral so that it can pass through the cation-selective (anion-repulsive) charge
clamp at the β-barrel via Brownian motion. After passing through the clamp,
deprotonation of these acidic residues on the higher pH side (trans side) prevents
peptide backsliding into the anion-repulsive clamp. When the substrate begins to
extrude from the pore, the conformational space of the chain is less restricted and
a helix-to-coil transition may occur, making the translocation thermodynamically
favorable because of an increase in configurational entropy. As substrate loses
structure in the stem, higher-pH solvent penetrates up the barrel as proton
dissipate out. The ΔpH at the φ-clamp thus weakens and φ-clamp switches to the
open state, releasing bound peptide for further translocation. While the α-clamp
continues to template the peptide into the pore, the cycle repeats until the
substrate is fully translocated.
Since the approach to the Brownian ratchet model is indirect, it requires
considerable works dedicated to piecing together the mechanisms. Though the
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ΔpH- and Δψ-dependent translocation has been established for some time, further
experimental evidence is needed to support this transport model.

Figure 1.4 Brownian ratchet model of anthrax translocation. A schematic
model of LF translocation through a PA pore with the indicated α-clamp, φ-clamp
and β-barrel charge clamp. The α-clamp may nucleate the unstructured leader
peptide into helix and feed it into the pore, where the φ-clamp can grip the leader
when ΔpH rises. Protonation of the acidic residues on the lower pH side
(endosomal side) converts the negatively charged residues (red dots) into neutral
(black dots), allowing for the peptides to move past the φ-clamp and the β-barrel
via Brownian motion. Deprotonation of these residues on the higher pH side
(cytosol side) and a helix-to-coil transition are thermodynamically favorable and
result in further translocation. The deprotonated sequence is unable to
retrotranslocate or backslide due to the β-barrel. Entropic tension in the upstream
folded substrate created by the clamps leads to domain unfolding so that further
cycles repeat until translocation completes. (Reproduced from Ref. 30.*)

*

Reproduced under CC-BY licence.
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1.2 Droplet-interface bilayer (DIB) system
The biological membranes are complex and challenging environments to
understand. While the patch-clamp technique50,51 is commonly used for
characterizing membrane proteins in their natural environment, a variety of
artificial mimics of the biological membrane have been developed for a better
control of each component of the membrane composition and its surroundings so
that the effects of individual factors can be studied. There have been a number of
different artificial membrane techniques, including tethered or supported lipid
bilayers, giant unilamellar vesicles or planar lipid bilayers (BLM).52-54 Among these
approaches, planar lipid bilayer (Figure 1.3a) provides easy access to both sides of
membrane to control over a variety of transmembrane conditions and has been
widely use in membrane protein studies. However, the requirements of
considerable amount of reagent for the aqueous chamber and other limitations
such as the inability of creating asymmetric lipid bilayers demand on the
development of other substitutive model membrane system. In the last decade,
droplet-interface bilayer (DIB) has been developed as an alternative platform for
the biophysical analysis of membrane protein.54-61 (Figure 1.5) When two aqueous
droplets (~200 nL each) with a lipid monolayer at their water-oil interface are
brought into contact, the droplet-interface bilayer is formed. The advantages of
DIBs are summarized here. First, the lipid bilayer in a DIB can be unzipped by
separating the droplets, allowing each side of the membrane to be handled
separately. As a result, it is possible to isolate and analyze the substrates by a
secondary experiment after translocation. Furthermore, since droplets can be
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separated or reattached easily, preparation time needed between each DIB
experiment is substantially reduced. Second, the typical volume needed for a DIB
at either side is 200 nL, which is much less than the 500 μL needed for a planar
bilayer chamber. Hence, there is little amount of protein or label needed.
Moreover, asymmetric lipid bilayer can be formed by dissolving controlled lipid
composition in each droplet that makes up one leaflet of the bilayer. In DIB, the
membrane is also robust enough to last hours as other model membrane systems.
A detection strategy that our lab developed for anthrax translocation using DIB
technique has been performed recently.62 After the substrate translocated through
PA pore from the first droplet into the second one, the captured substrate can be
further detected by monitoring its subsequent translocation via PA pore into the
third droplet. This work demonstrated the first substrates detection after
translocation other than the current changes in electrophysiology recording, in
which one can only obtain the information of pore open/close states instead of the
direct detection of substrate translocation.

11

Figure 1.5 Droplet interface bilayer (DIB). a. Diagram of droplet-interface
bilayer (DIB). b. DIB suspended from electrodes coated with hydrogel blob. The
electrodes are positioned using micromanipulators and connected to a patchclamp amplifier. Electrophysiology recording can be brought out in this setup.
(Reproduced from Ref. 61.*)

1.2.1 Perfusion systems based on model membranes or DIB
One of the most challenge limitations for the existing model membranes,
including DIB system, is the incapability of exchanging aquesous solutions
surrounding the membrane rapidly while maintaining the stableness of the
membrane. While reagents can be perfused to the planar lipid bilayer manually or
automatically, the milliliter chamber volumes are too large for instantaneous
delivery of precise solute concentrations to the membrane due to the long
diffusive length. Similarly, there is no reliable way to rapidly remove the reagents
introduced to the surroundings of the membrane. Therefore, the responses of the
membrane to the perfusing solutions in planar lipid bilayer system are elusive for
analyzing. Several research groups have developed microfluidic devices to achieve
rapid and controllable perfusion to the model membranes. For example, Shao et al.

*
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developed a chip in which a chamber is connected to a microfluidic channel
positioned both above and below the bilayer. 63 By flowing La3+ as inhibitor (or
EDTA as chelator of La3+ to reverse the inhibition) into the microfluidic channel to
ceramide channels on the bilayer, it took 20 s or more for the ceramide channels to
have a significant response to the reagents. However, this type of platforms suffers
from pressures across the fragile membrane, making it rupture easily during
perfusion. Moreover, it does not preserve the capabilities offered by DIB, such as
the ability to separate and reattach the droplets so that the membrane can be
easily reformed between each experiment. Therefore, others have developed
devices to make the DIB system more versatile. For example, Tsuji et al. confined
two large droplets (17 μL) within two circular wells, one of which is connected to
two microfluidic channels underneath the droplet.64 It took about 5−20 s to
introduce or remove the blockers of the α-hemolysin pores on the membrane.
However, the size of the droplets is relatively large such that the solution exchange
time is not ideal, especially because of the rupture of the bilayer under high flow
rate. Recently, our group has developed another DIB-based perfusion system,
which allows rapid and multiple perfusions to one side of a small DIB (~1μL).65
(Figure 1.6a) In this system, DIB forms between a movable droplet and a
perfusable droplet set on the top of the opening of a glass capillary. In the glass
capillary, pairs of fused silica capillaries are bundled together to infuse and
withdraw solutions simultaneously. Each pair of fused silica capillaries is
connected to a pair of syringes position on a same syringe pump with opposite
direction so that the rate of infusion and withdrawing can be exactly the same. In
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addition to the small volume of DIB, the flow directs to the plane of the membrane
without generating stagnant region in the droplet, leading to rapid buffer
exchange to the lipid bilayer. Demonstrated by perfusing and removing the
blockers of α-hemolysin pores on DIB, it was shown that the perfusion could be
completed within 5 s. (Figure 1.6b) Despite the advantages of this design, the DIB
membrane in this system is still very sensitive to the fluctuations caused by
uneven infusing and withdrawing rates, which is often generated from unexpected
pressure change throughout the system. Any small influence within the system,
such as twisted capillaries, tiny air or oil droplets trapped in the piping, easily
produces back pressure and disturbs the membrane in the system. Therefore, a
sophisticated perfusion system is still in demand.
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Figure 1.6 a. A perfusion device based on DIB. b. Demonstration of the
perfusions in the device by electrical recording. The perfusions of the blocker
(γ-cyclodextrin, blue bars on top) and buffer (red bars) in the presence of a single
α-hemolysin pore in DIB brought about rapid onsets and abolitions of binding
events. (Reproduced from Ref. 65.*)

1.3 Proton flux across membrane with pH gradient
With the realization that electrochemical proton gradients across biological
membranes play a fundamental role not only in anthrax unfolding and
translocation, but also in a variety of cellular energetics and regulations, different
tools have been employed to study passive or active proton flux through biological
and model membranes.66-71 Despite the complexity of the term proton flux, which
Reproduced from Ref. 65 with permission of The Royal Society of Chemistry. (License
Number: 4082631026139)
*
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is contributed from both proton and hydroxide fluxes, decay of pH gradients
across membrane or movement of proton-hydroxide in response to membrane
potentials can be monitored. For example, pH-sensitive probe molecules or the
measurement of conductance under applied voltage have been used for detecting
proton flux in different studies.67,72,73 It has been found that the magnitude of
proton flux through a plain membrane without ion channels varies from one
membrane system to another. For example, planar lipid bilayer usually contains a
solvent such as decane in the membrane. Interestingly, the permeability of the
bilayers increases ten-fold without the solvent.74 Also, non-specific leaks on
biological membrane produce permeabilities that are orders of magnitude greater
than artificial membranes.67 Other mechanisms, such as the differences in
membrane surface area, flip-flop rate of the lipid, bilayer thickness, the presence of
buffers, or weak acid protonophores present as contaminants, also have been
suggested to affect the results of proton flux measurements.66 Nevertheless, it has
been clearly shown that membrane permeability for proton-hydroxide is
significant larger than the values expected from that of other monovalent ions.
Typical permeability of proton-hydroxide (10−6 cm/sec) measured near neutral
pH75 is five to six orders of the magnitude over potassium or sodium permeability
(10−12 cm/sec) observed under similar conditions.67,76 As the aqueous volume of a
DIB is small (~1 μL), it is crucial to understand how proton flux through a ΔpH DIB
membrane with or without protein channels affects the stableness of the gradient.
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1.4 Molecules that block anthrax toxin
Since the symptoms of anthrax infections appear only after the bacteria
have multiplied inside the human host and started to produce the deadly toxin, the
infection can still be lethal even with antibiotic treatment at this stage due to the
accumulation of the toxins. In order to seek for an effective therapeutic strategy,
efforts have been devoted to develop therapeutic approaches include both
neutralization of toxin and antibiotic inhibition of bacterial growth.77-82 Ongoing
developments for toxin neutralization include receptor decoy-based antitoxins,
toxin-neutralizing antibodies, blocking of PA cleavage and oligomerization, and
inhibition of LF and EF association with PA pre-pore.80-82 Several inhibitors that
block PA pore and prevent LF and EF translocate across membrane have been
reported. For example, dominant-negative mutants of PA monomer that coassemble with the wild-type PA have been designed and demonstrated to have
ability to block the subsequent translocation of LF and EF across membranes.83
Likewise, a synthetic polyvalent peptide that binds to PA pre-pore was shown to
prevent the interaction between PA and its substrates.84 Based on structureinspired drug design, cationic β-cyclodextrin derivatives were also synthesized
and has been demonstrated to be an inhibitor of anthrax toxin both on singlemolecule and whole-organism levels.85,86 However, the design of this inhibitor was
inspired by the blockers of other heptameric membrane pores instead of PA
oligomers. In order to exploit the best value of structure-inspired drug design for
anthrax toxin, it is important to review small molecules with low molecular weight
that can dock on to PA pore and have high affinity with the toxin.
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1.5 Dissertation Overview
Brownian ratchet mechanism has been suggested as a model for describing
ΔpH-driven anthrax translocation.10,30 Understanding the mechanisms of toxin
translocation in anthrax will also be applicable to other toxin systems and will
empower strategies for fighting deadly bacterial infections. However, conventional
planar lipid bilayer technique limits the studies in detailed mechanisms of the
translocation. On the other hand, DIB system has been shown to be a powerful and
versatile model membrane system for a variety of membrane transport
mechanisms, including anthrax translocation.54,62 In this dissertation, the
development of novel strategies for studying anthrax translocation based on DIB
system will be described. By using these DIB-based techniques, important features
of anthrax translocation mechanism have emerged and will be described.
First, in order to establish the reliability of DIB system for studying protein
translocation across a membrane with proton gradient, I will demonstrate the
stableness of the pH gradient in DIB system in Chapter 2. By employing pHsensitive dyes, pH gradient change across DIB membrane with or without protein
channels was monitored. In this chapter, I will show that pH gradient can be
preserved in DIB up to several hours even in the presence of membrane pores.
In the Chapter 3, I will describe the development of a novel perfusion
system based on DIB technique. This is so far the most robust and stable DIBbased perfusion system that provides prompt solution exchange on one side of the
membrane. The system is able to accommodate more than six solutions for
different and repeated perfusions and is able to separate the droplets following
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each experiment. I will demonstrate how pH gradient across membrane can be
easily switched “on” and “off” and how protein insertion and translocation can be
performed and monitored in this system.
Following the development of the perfusion device, investigations in
anthrax translocation mechanisms using this device will be described in Chapter 4.
Since the major driving force of anthrax translocation is pH gradient, how the toxin
responses to the pH environment before, during, and after translocation in the
device is of interest. We found that while the substrate can be detached from the
translocase before the translocation is initiated by a ΔpH, it is trapped in the pore
if the ΔpH is abolished in the middle of translocation. To the best of our knowledge,
our group is the first one who can demonstrate a translocation with pauses and
restarts. I will show how the pauses and re-initiations of anthrax translocation
support and expand the Brownian ratchet model. Moreover, we have found strong
evidence of the structural change upon pH switches during translocations. We
further employed a mutant form of the substrate that cannot completely
translocate to investigate the conformational changes of and interactions between
the toxin proteins. I will describe how the jammed translocase expand the
mechanisms of anthrax translocation.
As we sought optimal conditions for studying mechanisms of anthrax
translocation in DIB perfusion system, we found two components used for
common buffers might block the translocase. In Chapter 5, I will summarize how
these small molecules affect PA pore. This provides not only the information of
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undesirable conditions that could be avoided in studying anthrax translocation,
but also insights into strategies for disabling the toxin.
Finally, in Chapter 6, I will summarize the advances of this dissertation both
in model membrane techniques and in mechanisms of anthrax translocation.
Suggestions of further research will be provided in this chapter to exploit the most
of the research in this dissertation.
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CHAPTER 2
STABILITY OF PROTON GRADIENT ACROSS A DIB

2.1 Overview
Anthrax is believed to use a proton gradient as the energy source to drive
protein translocation on cell membrane. In order to mimic the same translocation
on model membrane systems, it is important to understand if proton flux across
the membrane affects the overall proton gradient of the system. The model
membrane system we are interested in is droplet-interface bilayer (DIB), which
has several advantages such as the small amount of reagent needed or the
capability of isolating the aqueous compartments for further detection. However,
DIB has a very small aqueous volume (~1μL), it is therefore particularly crucial to
understand if proton flux through a proton-gradient DIB membrane affects the
stableness of the gradient. In this Chapter, a pH-sensitive fluorescent dye was used
to detect the proton concentration on both sides of a DIB membrane. We also
employed α-hemolysin (α-HL) and anthrax protective antigen (PA) pores to study
if the presence of membrane pores affects the proton gradient during a period of
time. We demonstrate here that the pH gradient across DIB membrane can last
hours even when membrane pores exist.
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2.2 Materials and Methods
2.2.1 pH sensitive fluorescent vesicle preparation
1,2-diphytanoyl-sn-glycero-3-phosphocholine (DPhPC, Avanti Polar Lipids)
dissolved in pentane was dried, rehydrated with different buffers (1 or 10 mM
Tris, 1 or 10 mM MES, 100 mM KCl, pH 5.5 or pH 8.5) and extruded 21 times
through a 100 nm-isopore membrane filter (Millipore Corporation) to make a 2.5
mM vesicle solution. The pH sensitive dye BCECF-dextran (2',7'-bis-(2carboxyethyl)-5-(and-6)-carboxyfluorescein, coupled with dextran, 10,000 MW,
Molecular Probes) was then mixed with each vesicle solution to a final
concentration of 50 μM BCECF in 2.5 mM vesicle. Dextran-coupled dye was used to
prevent the movement of the dye across the DIB membrane.

2.2.2 Proteins
Recombinant wild-type (WT) PA heptameric pre-pore expressed and
purified as described11,14,87 were generous gifts from Dr R. J. Collier (Harvard
Medical School) and Dr. B. A. Krantz (University of Maryland Baltimore). PA prepore was diluted in pH 8.5 buffer (10 mM MES, 10 mM Tris, 100 mM KCl, pH 8.5)
to a final concentration of ~60 nM. The WT heptameric staphylococcal α-HL was
kind gift from Dr. J. Clarke (Oxford Nanopore Technologies Ltd) and was diluted in
water to a final concentration of ~10 nM.
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2.2.3 The “Dimple” chip and fluorescence imaging
We designed a chip using SolidWorks CAD software and drilled a 10×10
array of circular hollows, named dimples, on the flat bottom of a well of the
polystyrene tissue culture plate (3.5 mL each, Corning) by a Roland MDX-40 rapid
prototyping machine. Each dimple is about 550 μm in diameter and has a depth of
250 μm at its center. The spacing between the adjacent dimple centers is 700 μm.
After fabrication, the dimple array was polished with toothpaste to prevent it from
rupturing the DIB placed on it. The chip was filled with 1 mM DPhPC dissolved in
hexadecane and left for an hour in order to form a thin lipid layer at its bottom so
that the vesicle droplets introduced later would not adhere to and stain the chip.
To prepare the vesicle droplets for DIB, 0.35 μL of fluorescent vesicle solution was
placed in a small eppendorf tube filled with hexadecane for one hour to form a
lipid monolayer-encased droplet. Each droplet was then transferred to a dimple on
the chip for fluorescence imaging. Droplets were imaged using a Nikon Ti-U
inverted fluorescence microscope with a 515 nm excitation filter cube and a
Coolsnap HQ2 digital camera. The average fluorescence intensity at the droplet
center (with a diameter of 200 μm) was then collected for data analysis. To form a
DIB and monitor the fluorescence change of each droplet within a time period (the
time-lapse imaging), two droplets were gently pushed to the adjacent dimples so
that they contacted with each other. Bilayers with diameters of 200~350 μm could
be formed and observed through the microscope. (Figure 2.1) The average
fluorescence intensity at each droplet center was collected every 10 minutes after
the two droplets contacted with each other.
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Figure 2.1 Two BCECF-containing DIB pairs with pH gradient on a dimple
chip. Four droplets were placed on a dimple in the chip and were arranged to form
two DIBs. Each DIB has one droplet in pH 5.5 and another in pH 8.5. The quantum
yield of BCECF is low at pH 5.5 and high at pH 8.5, thus the pH 5.5 droplets were
dimmer than the pH 8.5 droplets. (Top-left: pH 8.5, bottom-left: pH 5.5, top-right:
pH 5.5, bottom-right: pH 8.5)

2.2.4 DIB with electrophysiology recording and fluorescence imaging
DIB with electrophysiology recording was set up as previously described.61
In short, two droplets of 0.35 μL vesicle solution were suspended from two
movable, agarose-coated (∼3%, w/v) Ag/AgCl electrodes (one grounded and one
working) in a hexadecane bath. To form a pH-gradient DIB, droplet of pH 5.5
vesicle solution was placed on the grounded electrode and droplet of pH 8.5
vesicle solution was placed on the working electrode. Proteins, if any, were added
to the grounded side of the DIB by applying 0.2 μL protein solution to the agarosecoated grounded electrode before introducing the pH 5.5 vesicle solution. This
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protein droplet was then removed and two pH 5.5 vesicle droplets were used to
rinse away excess proteins by adding to and removing from the electrode one after
the other. A new pH 5.5 droplet was then added to the grounded electrode and
brought to the pH 8.5 droplet on the working electrode to form a DIB. The two
electrodes were connected to a patch-clamp amplifier headstage (Axopatch 200B,
Axon Instruments). Electrophysiology experiments were carried out as previously
described.61 Recordings were sampled at 5 kHz and low-pass filtered at 1 kHz with
a digitizer (Digidata 1440A, Axon Instruments). By using capacitance method and
the micromanipulator, the DIB membrane size can be monitored and controlled.88
Here bilayers with approximately 250–300 μm diameter were formed and the
electrophysiology was recorded to ensure the bilayer stability or protein activity.
After an hour, the droplets were separated using the micromanipulators and
removed from their respective electrode using a pipette. The droplets were then
transferred to the Dimple chip for fluorescence imaging. Another pair of droplets
was hung on the electrodes for an hour without contact each other and transferred
for fluorescence imaging in parallel. The fluorescence intensities of these control
droplets were used for data normalization described below.

2.2.5 Image analysis
In the time-lapse fluorescence imaging, the initial fluorescence intensity of
each droplet slightly fluctuates with discretely prepared samples. Our purpose in
this work is to analyze the fluorescence change contributed from pH-gradient DIB
along with elapsed time. Therefore, we normalized the obtained fluorescence
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intensity (FI) with the percentage difference (ΔFI) between the initial FI of each
droplet (FIi) and the following FI obtained at the elapsed time t (FIf,t):
𝑭𝑰𝑵,𝒕 = 𝑨(𝟏 + 𝚫𝑭𝑰)

Equation 2.1

where A is an arbitrary initial fluorescence intensity for each pH (𝐴 = 3500 for pH
5.5 droplet and 𝐴 = 7500 for pH 8.5 droplet) and FIN,t is the normalized
fluorescence intensity at elapsed time t.
For the fluorescence imaging following electrophysiology, in order to
eliminate the variation during transfer process, we employed a pair of controlled
droplets treated through the same process but did not form a bilayer. However,
the size of the droplet slightly differs from one to another. It is shown that the
fluorescence intensity observed is proportional to the droplet size. (Figure 2.2)
Therefore, We first normalized the observed fluorescence intensity (FI) for both
DIB droplets and controlled droplets using the following equation:
𝒓

𝑭𝑰𝑹 = 𝑭𝑰 𝟑𝟓𝟎

Equation 2.2

where FIR is the fluorescence intensity normalized by the ratio of droplet radius r
(μm) and an arbitrary radius that is 350 μm. Similar to 𝑭𝑰𝑵,𝒕 = 𝑨(𝟏 + 𝚫𝑭𝑰)
Equation 2.1, we further normalized FIR by using the percentage difference
(ΔFIR) between the FIR of DIB droplet (FIR, DIB) and the FIR of the control droplet
that did not form a bilayer (FIR, control):
𝑭𝑰𝑵 = 𝑨(𝟏 + 𝚫𝑭𝑰𝑹 )

Equation 2.3

where A is an arbitrary initial fluorescence intensity for each pH (𝐴 = 3500 for pH
5.5 droplet and 𝐴 = 7500 for pH 8.5 droplet) and FIN is the final fluorescence
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intensity we obtained through normalization. By the normalization, the trend of
the gradient change was manifest without pH calibration using dual excitation.

Figure 2.2 Fluorescence intensity increases with the droplet size.
Fluorescence intensity versus the radius of droplets with different pH was plotted.

2.3 Results and Discussion
The quantum yield of BCECF dye is low at pH 5.5 and high at pH 8.5. Here
we used the BCECF-containing DIB to demonstrate the stability of the bilayer with
pH gradient in DIB system. The BCECF we employed was conjugated with dextran
so that it does not leak out from the droplet. Therefore, only pH could affect the
fluorescence intensity of the droplet. In section 2.3.1, we first performed timelapse detections of pH-gradient DIB to monitor the pH change within each droplet
for a period of time. We then introduced α-hemolysin and anthrax PA pores to the
DIB membrane in section 2.3.2 to study if membrane pores eliminate the pH
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gradient by facilitating the proton flux. In order to ensure that the pores
functioned properly on the membrane, we performed electrophysiology recording
before fluorescence imaging.

2.3.1 Time-lapse fluorescence change of a pH-gradient DIB
In order to understand if DIB can sustain the pH gradient, we tracked the
fluorescence change of pH-sensitive dye BCECF in each droplet of a pH-gradient
DIB before and after the formation of the bilayer. (Figure 2.3a) To avoid creating
chemical gradients of the buffer salts, both droplets (pH 5.5 and pH 8.5) contained
MES and Tris salts. We used low concentrations for both salts (1 mM each) so that
minute gradient changes can be observed. Two lipid-monolayer-encased droplets
with BCECF-dextran, one at pH 5.5 and the other at pH 8.5, were placed on a
Dimple chip separately. The fluorescence intensity of each droplet was tracked
every 10 minutes for an hour. After an hour, the two droplets were brought
together to form a DIB and the recording continued. We noticed that the
fluorescence intensities of the two droplets drew closer to each other after their
contact. However, the intensities became stable and never meet each other an
hour after their contact. We attribute this change in intensity to proton flux from
the pH 5.5 side to the pH 8.5 side. The proton flux may be high when the bilayer is
just formed due to the rearrangement of the lipids. However, this effect diminished
as the bilayer became stable and the gradient could last for another hour.
The concentration of the buffer salts (Tris and MES) was relatively low (1
mM) in Figure 2.3a. We next increased the concentration of Tris and MES at either
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side of DIB to the typical buffer salt level (10 mM) to see if the fluorescence
intensity could be much more stable. A droplet with 1 mM Tris and 1 mM MES was
paired with another droplet 10 mM Tris and 10 mM MES to form a pH gradient
DIB. (Figure 2.3b) As our expectation, the fluorescence intensity of the droplet
with higher salt concentration did not change for two hours after the formation of
the bilayer. The fluorescence intensity of the droplet with lower buffer salt
concentration had the same trend as we saw in Figure 2.3a. This corresponds with
our hypothesis that the change in fluorescence intensity is mainly from the proton
flux through the bilayer since the fluorescence intensity of the droplet did not
change before forming a bilayer (Figure 2.3a) and was eliminated when the
concentration of buffer salts were increased (Figure 2.3b). Our results here
showed that pH-gradient can be brought out in DIB system and is stable over
hours with typical buffer salt concentration.
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Figure 2.3 a. The average time-lapse imaging of normalized fluorescence
intensity before and after pH-gradient DIB. The circle dots represent the
normalized intensities of pH 8.5 droplet and the square dots represent that of pH
5.5 droplet. (N=9) Both droplets contained 1 mM Tris and 1 mM MES. b. The pHgradient DIB with different buffer concentration. Top: pH 8.5 with lower buffer
salts concentration (1 mM) and pH 5.5 with 10 times higher buffer salts
concentration (10 mM).(N=4) Bottom: pH 5.5 with lower buffer concentration (1
mM) and pH 8.5 with 10 times higher buffer concentration (10 mM). (N=4)

2.3.2 Effect of pores on proton gradient across DIB
Anthrax PA pores and α-HL were introduced to pH-gradient DIB with low
concentration of buffer salts (1 mM) to see if their presence alters the gradient. We
first carried out the DIB on electrophysiology platform to ensure that the pores
functioned properly on the membrane. A membrane potential of +50 mV or −50
mV was applied throughout the recording with the protein pores at the grounded
side. Approximately 50−1000 pores were inserted on the membrane. After an
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hour, the pH 5.5 and pH 8.5 droplets were separated and transferred to the Dimple
chip for fluorescence imaging. Acquired fluorescence intensities were normalized
(FIN) and plotted into a box plot. (Figure 2.4) We found that all of the DIB pairs had
their FIN of pH 5.5 and pH 8.5 droplets closer than the control droplets that did not
form bilayer (which was normalized to FIN = 3500 for pH 5.5 and FIN = 7500 for
pH 8.5), indicating that the pH gradient across the membrane was reduced an hour
after DIB formation. This was similar to the results of our time-lapse fluorescence
imaging. We did not observe significant difference between the DIB pairs with and
without α-HL. However, although the number of PA pores did not show a
correlation with fluorescence intensity (data not shown), it was shown that pH 5.5
droplets of DIB with PA pores had a higher FIN than those without protein pores or
with α-HL, suggesting that protons dissipated from pH 5.5 droplet faster in the
presence of PA pores. Interestingly, pH 8.5 droplets of the DIB with PA pores did
not have significant difference compared to the pH 8.5 droplets of other DIB. Since
the proteins were added to the pH 5.5 (grounded) side, it was likely that PA might
influence the lipid monolayer structure and increase the dissipation of proton out
of the droplet through lipid monolayer. The proton movement through lipid
bilayer, on the other hand, did not seem to be altered significantly by the presence
of α-HL and PA pores.
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Figure 2.4 Box plot of the fluorescence intensities of pH-gradient DIB
droplets after forming the bilayer for an hour. A membrane potential of +50
mV or −50 mV was applied to the while the side of protein pores remained
grounded. The normalized fluorescence intensities (FIN) of pH 5.5 droplets (A) and
pH 8.5 droplets (B) from pH-gradient DIB with α-hemolysin (α-HL, N=2 for both
potentials) or PA pores (PA, N=8 for +50 mV and N=11 for −50 mV) were
compared with those without membrane pores (Blank, N=6 for +50 mV and N=11
for −50 mV) after forming bilayers for an hour. The box plot demonstrated the
distribution of the data points through their quartiles.

2.4 Conclusion
In this chapter, we used a pH-sensitive dye BCECF to monitor the pH
gradient across the DIB membrane. The dye was coupled with dextran so that it
does not penetrate out of each aqueous droplet. When we used a low
concentration of buffer salts, we could clearly observe proton moved from the low
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pH side to the high pH side and reduced the gradient after forming a bilayer
without protein pores. Nevertheless, proton movement did not alter the pH of
each droplet for hours when the concentration of buffer salts was raised back to
the typical level of buffer solutions. Therefore, we concluded that pH gradient
across membrane can be well maintained for hours in the DIB system. When
protein pores were introduced to DIB, we found that the presence of anthrax PA
proteins might facilitate the dissipation of proton out of the droplet through its
lipid monolayer. However, the proton movement across the lipid bilayer was not
altered significantly in the presence of PA pores. Our findings here provide
insights into the design of adapting DIB system to study pH gradient-driven
anthrax translocation. In fact, in our design of a novel model membrane system
based on DIB technique, which will be described in the next chapter, the pH of
protein-introducing side of the membrane can be preserved by continuously
perfusing buffers into it. Therefore, the pH would not be altered by the presence of
PA, which facilitates proton dissipation, so that the pH gradient across the
membrane can be maintained during the entire performance of anthrax
translocation on that system.
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CHAPTER 3
A NOVEL MODEL MEMBRANE PERFUSION SYSTEM
DEVELOPED BASED ON DIB TECHNIQUE

3.1 Overview
In order to characterize and study the functional properties of ion channels
and pores under controllable membrane environment, different simplified model
membrane systems have been developed.52-54 In planar lipid bilayer, one of the
most widely used model membrane platforms for decades that provides easy
access to each side of membrane, reagents can be perfused to or removed from the
membrane, providing access to electrophysiology study of how membrane pores
response to the changing environments. However, the large aqueous chambers of
planar lipid bilayer impede instantaneous delivery or removal of solute to or from
the membrane because of the long diffusive length. Also, the fragility and
unsteadiness of the membrane in this platform make it impossible to highly
increase the perfusion rate. Together, it is not only difficult to analyze the
responses of membrane to the perfusing solutions in planar lipid bilayers, but also
infeasible to apply this method to high-throughput systems for pharmaceutical
screenings.
There have been attempts to reconstitute artificial bilayers in microfluidic
systems with rapid perfusions.55,63-65,89-95 Effective perfusion in model membrane
systems requires high volumetric flow rate and minimum diameter of the
perfusing chamber. Most of the designs of model membrane with microfluidic
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system place horizontal lipid bilayers on the top of microfluidic channels;89,90,92,95
some also have channels above the bilayer.63,93 However, hydraulic pressure
disturbances during continuous high-rate perfusion in these systems often rupture
the membrane. Also, it is laborious and skilled to operate bilayer formation in
these systems. Others form membranes in perfusion systems by technique such as
droplet-interface bilayer.64 Droplet-interface bilayer (DIB) is formed by contacting
two aqueous droplets encased with lipid monolayer. (Figure 1.5) In addition to the
accessibility of DIB formation, other advantages such as the small aqueous volume
and the ability of forming asymmetric bilayers make DIB a robust, electrically
accessible alternative to model membranes. However, changes of droplet volume
lead DIB to rupture, making it difficult to achieve stable membrane with small
droplet volumes and high perfusion rate. Efforts have been made to overcome this
problem. For example, in order to counterbalance the disturbances magnified by
the small aqueous volume, a perfusion system was designed with two relatively
large droplets (17 μL) confined within two circular wells, one of which is
connected to microfluidic channels underneath the droplet.64 However, the
solution exchange time in this system is still not ideal, especially because of the
rupture of the bilayer under high flow rate.
Recently, our group has reported another DIB-based perfusion system,
which allows rapid and multiple perfusions to one side of a small DIB (~1μL).65
(Figure 1.6a) In this system, DIB forms between a movable droplet on top and a
perfusable droplet at bottom. In addition to the small volume of DIB, the perfusing
flow directs to the plane of the lipid bilayer without generating stagnant region in
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the droplet, leading to rapid buffer exchange to the lipid bilayer. However, the DIB
membrane in this system is sensitive to the fluctuations caused by uneven infusing
and withdrawing rates, which is often generated from unexpected pressure
change throughout the system. Small changes such as twisted capillaries, tiny air
or oil droplets trapped in the piping easily produces back pressures within the
system. In this case, small aqueous volume of DIB would be affected and the
membrane would eventually be ruptured.
In this Chapter, we developed a more sophisticated DIB-based perfusion
system. A large aqueous open reservoir is connected to the system so that the
pressure change within the system can be buffered and compensated. I
experimentally verified the effectiveness and stableness of this solution exchange
method by observing the insertion and translocation of anthrax toxin, which are
dependent on pH changes of the membrane environment. Protective antigen (PA)
is the pore forming protein that undergoes conformational rearrangement from its
pre-pore structure to the transmembrane pore upon acidification. The
translocation of the other two anthrax enzymatic components, lethal factor (LF)
and edema factor (EF), through the PA pore are driven by pH gradient across the
membrane. The N-terminal truncation form of the lethal factor (LFN), which is the
minimal translocation-competent leader domain of the lethal factor, was used as
substrate translocating through the PA pore in our demonstration.
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3.2 Materials and Methods
3.2.1 Proteins
Recombinant wild-type PA heptameric pre-pore and wild-type LFN
expressed and purified as described11,14,87 were generous gifts from both Dr R. J.
Collier (Harvard Medical School) and Dr. B. A. Krantz (University of Maryland
Baltimore). Proteins were aliquoted and stored in −80 oC before use. Before each
experiment, PA pre-pore was diluted in pH 8.5 buffer (10 mM MES, 10 mM Tris,
100 mM KCl, pH 8.5) to a final concentration of ~7 ng/μl for the perfusion system.
LFN was also diluted in pH 8.5 buffer to a final concentration of ~250 ng/μl for the
perfusion system.

3.2.2 Fabrication and preparation of DIB-based flow chip
A schematic of the flow chip design and operating mechanism is shown in
Figure 3.1. Briefly, microchannel architectures were designed using SolidWorks
CAD software and milled on acrylic with a Roland MDX-40 rapid prototyping
machine. A smaller perfusion well (diameter: 1.5 mm, depth: 4 mm) was
connected to a larger pressure control port (diameter: 5 mm, depth: 4.5 mm)
through a lateral channel. Six fused silica capillaries (OD: 280 μm, ID: 150 μm)
were bundled and glued (z-poxy) inside a PFA tube (OD: 1/16 in. ID: 0.04 in.). If
needed, more capillaries are also accommdable to the chip. This inlets bundle was
screwed upright into the perfusion well of the chip by a one-piece fingertight male
nut. Each capillary had a MicroTight adaptor fitting at the other end, which in turn
was connected to a 500 μL gastight syringe (Hamilton) by a female Luer adaptor.
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Another PFA tube was screwed into the large port of the chip and connected to a
500 μL gastight syringe as the drain. All tubes extended through a hole of the
Faraday cage surrounding the flow chip. Each syringe was placed on a syringe
pump (NE-300, New Era Pump Systems, Inc.) outside the Faraday cage while the
drain syringe was arranged to opposite orientation of the pump so that it
withdrew.
Before use, acrylic piece was coated with agarose to prevent hexadecane or
air trapped in the channel by applying a thin layer of agarose solution (∼0.2%,
w/v) to its inner surface. Although up to six solutions can be independently
perfused from the inlet syringes, here we only used four to demonstrate the
perfusion: pH 8.5 buffer (10 mM MES, 10 mM Tris, 100 mM KCl, pH 8.5), pH 5.5
buffer (10 mM MES, 10 mM Tris, 100 mM, pH 5.5), PA heptameric pre-pore (~7
ng/μl in pH 8.5 buffer) and LFN (~250 ng/μl in pH 8.5 buffer). Hexadecane was
added on the top after introducing aqueous solutions in the flow chip.

3.2.3 DIB preparation and electrophysiology
1,2-diphytanoyl-sn-glycero-3-phosphocholine (DPhPC, Avanti Polar Lipids)
dissolved in pentane was dried, rehydrated with pH 8.5 buffer and extruded 21
times through a 100 nm-pore filter to make a 2.5 mM vesicle solution. To form a
DIB, 1.0 μL of vesicle solution was placed on top of the perfusion well to create one
monolayer-encased dome. The other 200 nL droplet of pH 8.5 vesicle solution was
suspended from a movable, agarose-coated (∼3%, w/v) Ag/AgCl electrode, which
was the working electrode connected to a patch-clamp amplifier (Axopatch 200B,
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Axon Instruments). An Ag/AgCl electrode was inserted into the pressure control
port and was electrically grounded. Electrophysiology experiments were carried
out as previously described.61 Recordings were sampled at 5 kHz and low-pass
filtered at 1 kHz with a digitizer (Digidata 1440A, Axon Instruments). Bilayers
with approximately 300–350 pF capacity were formed by bringing the droplet into
contact with the dome. Solutions were flowed through the dome under a rate of
0.03 mL/minute using two syringe pumps so that one syringe infused a solution
simultaneously with the withdrawing drain syringe. Proteins and buffers were
perfused to the grounded dome. Control experiments with empty membrane and
buffer perfusion showed no activity. All voltages reported were those of the
droplet side. After insertion of PA pore, pH 8.5 was perfused to the dome and the
current drift across the membrane was offset at zero voltage. A low negative
voltage (10–20 mV) was held throughout the translocation experiments.
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Figure 3.1 a. Diagram of the DIB perfusion system. The aqueous chamber
(blue) consists of 4 openings (i) an injection pore with up to six microcapillaries
bundled together (ii) a drain (iii) a large pressure control port and (iv) the DIB
port. The pressure control port is slightly higher than the DIB port and is used to
prevent pressure changes under the DIB. Two electrodes are used, one grounded
and one working. The working electrode is connected to manipulator so that the
size of the DIB can be regulated. b. Top view of the DIB perfusion system.

3.3 Results and Discussion
In order to overcome the limitation of conventional planar bilayer system
or DIB system, we designed a novel flow device to study anthrax translocation. In
this section, operation of the flow device and the electrophysiology recording of a
typical anthrax translocation on the device as demonstration are described.

3.3.1 Description of DIB formation and flow chip operation
We designed and constructed a microfluidic device to facilitate the rapid
exchange of solution on one side of a DIB membrane (Figure 3.1). A small aqueous
dome was formed atop one end of a vertical U-shaped channel machined into
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transparent acrylic plastic. The other end of the channel was connected to a fluid
reservoir. The aqueous dome was approximately 1 mm in diameter while the
reservoir was approximately 5 mm in diameter. When full, the aqueous dome was
level with the surface of the large reservoir. Seven fluid conduits could be
connected to the device at once and each was driven using a syringe pump. Six
pumps were operated in “inject” mode, while the last syringe was reversed on the
final pump to “withdraw.” During flow, two pumps, one of them injects and the
other withdraws, were operated simultaneously so that the net volume of the
aqueous dome and the entire device remained constant. The large reservoir
essentially served as a baffle to suppress any effect from uneven flow rates in the
device. In this way, flow rates of up to 1 μL/s (where 1 μL is roughly the volume of
the aqueous dome) could be achieved without any visible disturbance of the
volume. Just below the surface of the dome, a bundle of 6 fused silica capillaries
(Figure 3.1b, DIB port) was arranged pointing upward. Thus, injected fluid
impinged directly on the surface of the aqueous dome. Excess fluid flowed down
around the capillary bundle toward the drain. The capillaries were secured in
place by gluing them inside a larger Teflon tube. This geometry allowed us to
quickly switch the aqueous environment on the bottom side of the DIB.
To form a membrane, the device was first filled with aqueous buffer and
then filled with hexadecane. One droplet of pH 8.5 1,2-diphytanoyl-sn-glycero-3phosphocholine (DPhPC) vesicle solution was placed on an Ag/AgCl electrode
above the dome while another electrode (which as electrically grounded) was
dipped into the large reservoir, which was connected to the dome. The electrode of
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the upper droplet was the working electrode connected to a patch clamp amplifier
while the electrode in the large reservoir was the electrically grounded electrode.
A droplet of lipid vesicles was added to the dome to allow monolayer formation.
After the droplet and the dome formed monolayers, the two surfaces were
contacted by lowering the droplet onto the dome via micromanipulator.
Membrane formation was monitored via capacitance measurement.88
The pH of the top droplet of the DIB was fixed at 8.5 in the testing
experiment. In Figure 3.2, it was shown with electrophysiology that the membrane
was stable when two different buffers were perfused by turns to the DIB from two
syringes on different pumps in a flow rate of 0.5 μL/s. The reagents can thus be
perfused or removed within 2 seconds. The membrane is stable under continuous
flow up to a few hours by this method. In such a way, this device promises a
powerful and robust lipid bilayer perfusion platform that provides new
possibilities in the area of the responses of membrane pores to the changing
environments.
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Figure 3.2 Stableness of DIB during perfusions in the flow chip. After the
bilayer formed, +50 mV or -50 mV was applied to the membrane to exam the
stability of the membrane. (Top) The grey shaded areas indicate when a triangle
wave with 2.5 mV amplitude and 100 Hz frequency was applied to generated a
square wave current pulse (bottom, the black blocks) with an amplitude that
corresponds to the capacitance of the bilayer. This method allows for monitoring
the bilayer size.88 The amplitude of the output current square wave is proportional
to the diameter of the bilayer when acquiring at 2.5 kHz. For example, a 350 pA
square wave output indicates a bilayer of diameter approximately 350 μm. The
blue and red bars indicate different solutions perfused through the grounded
dome of the DIB flow chip with the top droplet remains constant at pH 8.5. It
showed that bilayer size was stable without leakage during different perfusions.
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3.3.2 The pH activation of anthrax pore formation and translocation using
the flow chip
As a demonstration, the flow chip was used to monitor the anthrax pore
formation and translocation. Anthrax PA pore formation is triggered by
acidification of its environment. The translocation of the substrate through the PA
pore is driven by pH gradient, referred to as ∆pH, with the lower pH at the
substrate side. In our work, the pH gradient was generated by perfusing the
aqueous dome under the DIB with an acidic solution. (Figure 3.1) The pH of the
top droplet of the DIB was fixed at 8.5 throughout the experiment. The pH
gradient, referred to as ∆pH (∆pH = pHdroplet − pHdome), was generated by
perfusing the aqueous dome under the DIB with an acidic solution. When the
dome was perfused with a pH of 8.5, the ∆pH = 0; when the dome was perfused
with pH 5.5, the ∆pH = 3. The dome was connected to the electrically grounded
electrode while the upper droplet of the DIB was connected to the working
electrode of a patch clamp amplifier. All reagents, including PA pre-pores,
substrates, and buffers were introduced to the dome using syringe pumps in a rate
of 0.5 μl/s. We chose to use a truncated form of LF called LFN for the translocation
experiments presented here since its translocation is more efficient.11 LFN
contains the N-terminal pore binding domain of LF and is the first component of
LF to enter the PA pore during translocation.87,96,97 LFN represents ~30% of the full
length protein and had been shown to have a translocation half life of about 50
seconds with a ∆pH =2 at a membrane potential of −20 mV.28 The efficiency of the
translocation of LFN is about 20% higher than that of full length LF or EF,11 thus it
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has been widely used for precedent studies in anthrax translocation. 13,24,25,2830,42,45,49,98-102

In the translocation experiment, the DIB membrane was clamped at a
potential of −10 or −20 mV (Δψ ≡ Δψdroplet − Δψdome; Δψdome ≡ 0 mV) to facilitate
ionic current recording. (Figure 3.3) Although it has been previously
demonstrated that a voltage gradient can induce LFN translocation, a potential of
−20 mV is far below the required threshold and did not contribute a significant
translocation force.13,97 Applying a small negative voltage, however, fosters the
entry of positively charged N terminus of LFN attracted into the channel by
electrostatics.13,97 Moreover, PA pore insertion and LFN translocation could be
observed by monitoring ion current changes with the applied voltage. After a
symmetric pH 8.5 DIB is formed on the flow chip, a solution of 7 nM PA pre-pores
in pH 8.5 buffer was first introduced for ~10 seconds (Figure 3.3, points A-B). The
ionic current did not change since PA pre-pore is stable in solution at pH ≥ 88 and
did not convert to the pore at this stage. Next, pH 5.5 buffer was injected to initiate
pore formation and insertion (Figure 3.3, B-C). Inoic current rapidly increased,
indicating insertion of PA pores onto the membrane, and then reached a steady
level around −1000 pA (which represented ~800 PA pores on DIB39,62) as excess
pores were rinsed away by the buffer. If needed, these two steps (introduction of
PA pre-pores and insertion of PA pores) could be repeated multiple times to
achieve the desired number of pores. We noted that the open pore current was
dependent on the buffers used (Figure 3.3, C-D). When ∆pH = 3 was switched to
∆pH = 0, there was a nearly 50% increase in conductance of the pores. To avoid
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creating chemical gradients due to differing buffer salts so that a simplified system
could be achieved and the effects of pH change could be well focused, both buffers
contained same concentration MES and Tris salts. However, the pH 5.5 and pH 8.5
buffers required different amounts of KOH as titrant and thus had a slight
difference in overall conductivity. Specifically, the pH 5.5 buffer had 13.9 mS/cm
conductivity while the pH 8.5 had 14.6 mS/cm conductivity. If the 50% increase in
conductance of PA pore was contributed from the different amounts of the titrant,
the conductivity of the pH 8.5 buffer should be at least twofold higher than the
conductivity of the pH 5.5 buffer.103-105 As the electrochemical driving force
contributed from this conductivity gradient is also negligible, we do not account
the difference in conductivity of the buffered solutions for the change in
conductance of PA pore during pH modulation. Therefore, it is likely that
conformation changes (such as the open-closure switches of the φ-clamp39,43,106)
accounts for the higher conductance at pH 8.5. The ion current stably switched
between the two levels when pH 5.5 and pH 8.5 were alternately introduced
(Figure 3.3, C-F. The two current levels of the empty pores are labeled as EMT∆pH=3
and EMT∆pH=0), indicating that the number of pores on DIB did not change and the
system was reliable during the perfusions. After the PA pores were formed, LFN
(275 nM) at pH 8.5 was then introduced and allowed to bind to the PA pores
(Figure 3.3, F-G). LFN binding was observed in the electrical recording usually as a
~30-45% decrease in open pore current at pH 8.5 (ΔpH = 0), presumably depends
on the percentage of the activity of the batch PA pores. The partially LFN-blocked
state (Figure 3.3, current level at the preloaded state PL∆pH=0) was stable for long
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time periods reaching 20 s; therefore we surmise this was a stable state of the
system. Previous reports have shown that when the ΔpH is negative or when the
ΔpH = 0 with pH 5.5 at both sides of the membrane, LFN did not translocate under
−20 mV.28,29 Here, we show that at the LFN preloaded state, with both
compartments at pH 8.5, there was no ∆pH and translocation did not occur. This
corresponded with our expectation based on the Brownian ratchet model. When
the aqueous dome solution was exchanged to pH 5.5 buffer within 1.5 s, we
observed a typical and highly-reproducible translocation profile (Figure 3.3 G-H).
It is important to note that the introduction of pH 5.5 solution at point G both
creates a ΔpH and rinses away all excess LFN in solution. At first, the LFN almost
completely blocked all pores (Figure 3.3, current level at the fully blocked state
FB∆pH=3), presumably by threading through and blocking the flow of ions. At the
fully blocked state, we observed a small residual current around 5% of the current
level EMT∆pH=3, which was probably affected by the activity of the batch PA pores.
This was followed by a slow increase in current, which likely represented the
increasing number of empty pores. As all LFN peptides exited the pores, the
conductance of the pores is re-established (Figure 3.3, H-I). By point H in Figure
3.3, all pores were fully open and all LFN has been translocated.
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Figure 3.3 Anthrax pore insertion and translocation with switches of pH
gradient across the membrane on the flow chip. (N>10) A negative voltage (–
20 mV) was applied throughout the recording. The bars with different colors on
the top indicate perfusion durations of different solutions through the grounded
bottom dome of the DIB perfusion system (with the top droplet remains constant
at pH 8.5). The different colors of the trace indicate different states of the current
in respond to the perfusions. Points A-B: When PA pre-pores were introduced in
pH 8.5, no current was observed. Points B-C: pH 5.5 buffer was introduced so that
PA pre-pores converted to pores and inserted on DIB membrane. Points C-F: pH
8.5 and pH 5.5 buffers were rinsed to the pores. The current passing through these
empty pores was stable but responded differently to pH 8.5 (∆pH =0) and pH 5.5
(∆pH =3) conditions (levels indicated as EMT∆pH =0 and EMT∆pH =3). Points F-G: LFN
was introduced in pH 8.5 (∆pH =0), a partially blocked state was observed (level
indicated as preloaded state PL∆pH =0). Points G-H: pH 5.5 buffer was introduced to
the LFN-loaded pores (∆pH =3) and initiated the translocation. The current was
first reached to a fully-blocked state (level indicated as FB∆pH =3) and then
increased until the translocation completed. Points H-I: pH 8.5 and pH 5.5 buffers
were rinsed to the pores after translocation, the current was the same as before
loading LFN.
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This experiment clearly demonstrated that the flow chip we developed is
capable of executing rapid and multiple perfusions. PA pores on the membrane
responded to each perfusing solution within 2 seconds and is incredibly stable
throughout the experiment. From this specific experiment, we also gained insights
into anthrax translocation. Previous literature reports show that PA can bind three
LFN per heptameric pore22,24,107 on its top with high affinity (Kd ~200 pM25). Since
LFN was introduced in excess relative to the number of pores, we assumed that all
pores were saturated with LFN. Also, the narrow lumen of the PA pore can only
accommodate one peptide strand to translocate at a time.39,43 Thus, we interpret
the blocked state as the entry of LFN into the narrowest region (the φ-clamp) of all
of the PA pores and the following increase in current as increase in population of
the empty pores. Therefore, the curve between points G-H could represent the
recurrent trafficking of up to 4000 LFN molecules. In our experiments, the halftime of translocation was measured from the fully blocked state and was
estimated to be 21.7 ± 0.7 s (N=10), corresponding with the 50 s translocation
half-time in a smaller pH gradient (∆pH = 2, ∆ψ = 20 mV) recorded in previous
reports.28,29 Overall, our flow device offers the promise of multiple and continuous
perfusions without affecting the stability of proteins on membrane. By utilizing
our flow device, different stages of LFN translocation through PA pore was clearly
monitored in appreciable stability. Further studies were performed in the next
chapter to investigate the translocation mechanism and the conformational
changes of the anthrax toxin.
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3.4 Conclusion
In this chapter, a novel microfluidic chip developed based on DIB technique
was described. Anthrax toxin was used to demonstrate the fast responses of
membrane pores to the changing environment. Our technique of DIB-based
perfusion system enables us to reconstitute or mimic the changing environment of
cellular membranes under a variety of controls. The membrane formed in the chip
is able to sustain rapid perfusions and has been shown to be stable even after
multiple perfusions over a period of time. This perfusion system is much more
stable and has more utility than other similar perfusion systems. The perfusion
rate that can be performed in this chip is also higher so that the reagents can be
perfused to or removed from the membrane within 2 seconds. This perfusion
system will further enhance the acquisition of delicate responses of ion channels
to their environments as it can deliver a precise concentration of solute to the
membrane within 2 s. For example, the functional mechanisms of pH-sensitive
potassium channels such as twik-related K+ channel (TREK)108 or KcsA channel109
can be easily performed. Also, our technique holds much promise for the highthroughput screening for ion-channel targeted drug discovery. Our work not only
presents a powerful perfusion platform that is broadly applicable to studies in
membrane pores, but also implies possible conformational changes during anthrax
translocation.
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CHAPTER 4
ITERATIVE ACTIVATION OF A BROWNIAN RATCHET
USING THE NOVLE DIB-BASED FLOW DEVICE

4.1 Overview
Anthrax toxin is a binary A/B toxin using its own machinery to form
transmembrane pores to gain entry into the cytosol and disrupt the metabolic
steps of the host cell.5-10 It is an ensemble of three individually nontoxic
multidomain proteins:7,11,14-16 a receptor-binding component called protective
antigen (PA, 83 kDa) and two enzymatic components named edema factor (EF, 89
kDa) and lethal factor (LF, 90 kDa). After PA binds with cellular receptors on the
surface of the target cell, a 20 kDa piece from its N-terminal side is cleaved off and
leaves the remaining 63 kDa portion (PA63) on the receptor. PA63 subsequently
self-assembles into a heptameric or octameric pre-pore, which is capable of
binding up to three or four molecules of LF, EF, or both to generate a pre-pore
complex that is then endocytosed.19-25 Upon acidification of the endosome, PA prepore converts to a pore structure that inserts into the endosomal membrane21,26,27
and translocates EF and LF into the cytosol.28-30 While the proteolytic activation of
PA is carried out in vivo by furin-family proteases, it can be replicated in vitro with
trypsin.7,8,12,20,37 When PA63 monomer is purified from trypsin-activated 83 kDa
PA, it is found to spontaneously self-oligomerize into the heptameric ring-shaped
pre-pore structure, which is stable in solution with pH above 8.7,16,20 This allows
the studies of anthrax translocation to be performed on the model membrane
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systems without cellular receptors. It has been demonstrated that either proton or
potential gradients on planar lipid bilayer can induce translocation of toxins
through PA pore.13,28,29 A putative Brownian ratchet model of proton-gradientpowered translocation of anthrax toxin has been postulated based mainly on
studies using model membranes.10,30 It has been proposed that two catalytic active
sites of PA pore engage in the Brownian ratchet, including the α-clamp,9,10,25,45 the
substrate docking cleft on the top of PA pore, and φ-clamp, the narrow
constriction point about one-third of the distance into the translocase.28,39,40,43,46
However, deconstructing the tandem Brownian ratchet model is challenging in
planar lipid bilayer, making it difficult to verify the structural and functional
mechanisms of anthrax translocation.
In this Chapter, we use the novel droplet-interface bilayer (DIB) perfusion
system demonstrated in Chapter 3 to track different steps along the translocation
of LFN, which is the N-terminal PA-binding domain as well as the minimal
translocation-competent domain of LF with high translocation efficiency,87,96,97
through PA pore. We show that translocation can be initiated, paused, or reinitiated by switching different pH environments of the membrane, providing
strong evidence for a Brownian ratchet model. Our results also reveal structural
mechanisms of the PA clamps and substrate structure underlying anthrax
translocation ratchet machinery. Collectively, these results delineate the
interactions between substrate and membrane pore by which the substrate is
translocated into the cytosol using proton gradient.
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4.2 Materials and Methods
4.2.1 Proteins
Both recombinant wild-type PA heptameric pre-pore and wild-type LFN
expressed and purified as described11,14,87 were generous gifts from both Dr R. J.
Collier (Harvard Medical School) and Dr. B. A. Krantz (University of Maryland
Baltimore). The hairpin LFN (LFNC8C, a gift from Dr. Krantz) had an unstructured
25-residues peptide of Gly (G), Ser (S), Thr (T) appended on the C-terminal end of
LFN. Within the G,S,T 25-mer, two Cys residues were engineered 8 residues apart
and oxidized into a disulfide bond. Proteins were aliquoted and stored in −80 oC
before use. Before each experiment, PA pre-pore was diluted in pH 8.5 buffer (10
mM MES, 10 mM Tris, 100 mM KCl, pH 8.5) to a final concentration of ~7 ng/μl for
the perfusion system. LFN or LFNC8C was also diluted in pH 8.5 buffer to a final
concentration of ~250 ng/μl for the perfusion system.

4.2.2 Preparation of DIB-based flow chip
The general preparation of DIB-based flow chip has been described in
section 3.2.2. In this Chapter, up to six solutions were independently perfused
from the inlet syringes: pH 8.5 buffer (10 mM MES, 10 mM Tris, 100 mM KCl,
titrated to pH 8.5 with KOH), pH 5.5 buffer (10 mM MES, 10 mM Tris, 100 mM or
200 mM KCl, titrated to pH 5.5 with KOH), PA heptametic pre-pore (~7 ng/μl in pH
8.5 buffer), LFN (~250 ng/μl in pH 8.5 buffer), LFNC8C (~250 ng/μl in pH 8.5
buffer), and TCEP (10 mM in pH 8.5 buffer). Hexadecane was added on the top
after introducing aqueous solutions in the flow chip.
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4.2.3 DIB preparation and electrophysiology
DIB preparation and electrophysiology recording method were the same as
those described in section 3.2.3.

4.3 Results and Discussion
According to Brownian ratchet translocation model, anthrax translocation
requires repeated cycles of acidic residue protonation and deprotonation on either
side of the φ-clamp.10,30 (Figure 1.4) That is, it demands the proton gradient across
the membrane to be present throughout the whole translocation and that the
cargo cannot be retro-translocated once it enters the ratchet. We therefore
hypothesized that if the gradient is abolished when LFN is only partially
translocated, the peptide would remain in the pore indefinitely without forward
translocation or backsliding. If we are able to suspend the translocation by altering
the pH gradient, it will not only provide the strongest support for Brownian
ratchet model, but also allow us to investigate the interactions between PA pore
and the substrate trapped within it. For example, it has been proposed that PA
sites such as the φ-clamp may switch conformation during the substrate
protonation/deprotonation cycle.9,10 Thus it might be possible for us to observe
this conformational change of the pore and the substrate if we can cease the
protonation in the middle of translocation. I have shown in Chapter 3 that we are
able to switch the pH gradient rapidly and perform pore insertion and LF N
translocation on the DIB-based perfusion system. In this section, we employ the
same perfusion system to study how pH environment affects the interactions
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between LFN and PA pore and the translocation. In this system, the pH gradient
(∆pH) of the membrane can be switched to ∆pH = 3 when the aqueous dome
(grounded side) under the DIB was perfused with pH 5.5 while the top droplet was
fixed at pH 8.5. (Figure 3.1 a. Diagram of the DIB perfusion system. The aqueous
chamber (blue) consists of 4 openings (i) an injection pore with up to six
microcapillaries bundled together (ii) a drain (iii) a large pressure control port
and (iv) the DIB port. The pressure control port is slightly higher than the DIB port
and is used to prevent pressure changes under the DIB. Two electrodes are used,
one grounded and one working. The working electrode is connected to
manipulator so that the size of the DIB can be regulated. b. Top view of the DIB
perfusion system.Figure 3.1) When the dome was perfused with pH 8.5, the ∆pH =
0. All regents such as proteins and buffers were added to the grounded side in our
works as we did in Chapter 3.

4.3.1 Anthrax pore-formation and activation of translocation as controls
In section 3.3.2, I have described the pore formation and translocation
activation of anthrax toxin by introducing pH gradient (∆pH) to the membrane. In
this Chapter, most translocation experiments began with a control translocation
similar to Figure 3.3 to confirm the activity of the PA pores and LFN peptides.
Specifically, our experiments used 1,000 to 4,000 pores. This allows for
observation of minute residual current in the fully blocked state, if any is to be
found. Pores were introduced by switching to low pH conditions on grounded side
of the membrane. This inserted all the pores at the same time and fixes the
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number of pores during the experiments as all excess pores are washed away. The
two different current states of the PA pore in response to ∆pH = 3 and ∆pH = 0
(Figure 3.3, EMT∆pH=3 and EMT∆pH=0) is suggested as the conformational change of
the φ-clamp. Next, LFN (Kd ~200 pM25) was always introduced in excess, thus we
surmise that the pores were fully loaded before each experiment. In other words,
the docking sites of each pore were fully saturated prior to any experiment. Also,
the introduction of LFN at pH 8.5 allowed the pores to be loaded under nontranslocating conditions. The time needed for the initiation of pH driven
translocation after loading LFN was typically 2 seconds, which was far shorter than
the time needed for LFN detachment (later shown in section 4.3.2). Therefore we
assume all PA pores were fully saturated with LFN before translocation initiation.
From previous reports, it is apparent that PA heptameric pores may accommodate
as many as three LFN peptides.22,24,25,107 Thus, in all translocation experiments, we
expect that each PA pore translocated multiple copies of LFN when the pH gradient
was applied. The initiation of the pH gradient produces one of the key features
observed in our experiments. Immediately upon introducing pH 5.5 buffer into the
grounded compartment with LFN-loaded pores on the DIB, the current was rapidly
blocked – reaching to a brief plateau – before sweeping to an open state (for
example, Figure 3.3 after point G). We interpret the blocked state as the entry of
LFN into the φ-clamp region of all of the PA pores and the following increase in
current as increase in population of the empty pores.
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4.3.2 Interaction between LFN and pore is slowly reversible before entering
the ratchet
In section 3.3.2 and 4.3.1, it has been shown that under LFN saturating
conditions, the PA pores remain stably blocked to roughly 40% of open pore
current when ∆pH = 0 (Figure 3.3, points F-G). However, if it is perfused with pH
8.5 buffer after this stage, a gradual increase in current is observed (Figure 4.1,
points B-C), suggesting LFN is removed from the pore. This corresponds to
previous studies, in which LF can be detached from PA pores in pH ~8.14 Upon
setting ∆pH = 3, remaining LFN still translocated (Figure 4.1, points C-E). In the
control experiment, a brief plateau of 5 s with a current change < 50 pA was
observed after total pore blockage (Figure 4.1, the 5 s plateau region in control),
suggesting a stage when no pore has yet completed translocation all of the bound
LFN copies. This plateau, however, was far shorter (< 2 s) in the LFN-reduced
translocation (Figure 4.1, point D). Also, this blocking current was higher than the
fully blocked state in control. Of interest, the translocation half-time of the LFNreduced trial was also roughly 5 s shorter than the control. All of these support
that there was less LFN peptides bound to PA pores after washing away at pH 8.5
when pH 5.5 buffer was perfused to initiate translocation. Prior to translocation, it
is believed that the N-terminal sequence of LF binds to the pore (presumably the
α-clamp), but does not enter the narrow constriction region (φ-clamp) until the
∆pH is established.9,25,28,39 The transition from PL∆pH=0 to FB∆pH =3, i.e. the partial
blockage of PA pores at ∆pH = 0 in the presence of LFN and the full blockage of PA
pores at ∆pH = 3, supports this hypothesis and our data here also indicates that
the interaction between the LFN and the α-clamp is reversible prior to
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experiencing a pH gradient. Moreover, since each PA heptameric pore can bind up
to three LFN molecules22,24,107 while PA pore can only accommodate one peptide
strand at a time39,43, translocation would likely start with one LFN entering the φclamp of the pore while the other peptides remaining attached to their respective
PA binding sites. The remaining LFN may either detach or enter the pore once the
previous LFN has translocated. Our results indicate that the latter is favored during
a pH gradient, while detachment occurred when there was no pH gradient, albeit
more slowly (> 50 s before increasing to half of the preloaded state) than the
translocation process (in control, translocation half-time was 22 s). (Figure 4.1,
points B-C)
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Figure 4.1 Detaching LFN from PA pore before translocation began. (N =2) A
voltage of –20 mV was applied throughout the recording. First, PA pores were
loaded with LFN and a full translocation of was performed. This control
experiment verified the nominal function of the pores. A 5 s plateau was observed
after the pores were fully blocked by LFN. Points A-B: After the control, LFN was
reloaded to the pores in pH 8.5 for 20 s and a partially blocked state was observed.
Points B-C: pH 8.5 buffer was perfused to DIB to for 50 s. The current slowly
increased as LFN peptides were detached from the pores. Points C: Translocation
was initiated with application of ∆pH = 3. Points D: The re-blocking peak had a
shorter plateau (< 2 s) and higher residual current. Point E: Translocation
proceeded to completion. PA pores was rinsed with pH 8.5 and pH 5.5 respectively
after point E.

The small decrease in current during LFN introduction at pH 8.5, ∆pH = 0
(Figure 3.3, points F-G) was uniformly observed in all experiments, including those
using the hairpin form of LFN (Figure 4.8, points A-B). When we introduced LFN at
pH 8.5 and then rinsed at pH 8.5 to see whether LFN could be detached (Figure
4.1), we observed a slight increase in current, suggesting that LFN can slowly
release from the binding site over time. The decrease in current during LFN
loading is likely due to the partial occlusion of the opening at the top of PA pore by
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the leader sequence of LFN. Crystal structures of PA and LFN complex have shown
that the α-clamp binds to a substrate helix and orients the substrate strand into
the central lumen of PA pore at pH 8.25 Therefore, LFN likely already binds to the
α-clamp site at this preloading stage. In the allosteric helix compression
mechanism that is currently proposed45,110,111, substrate helix binding to the αclamp site triggers the φ-clamp to convert to a more closed state that forces the
helix into an extended chain that subsequently passes through the charge clamp
beneath the φ-clamp. Here, we propose binding between substrate and the αclamp along in the higher pH does not trigger the φ-clamp to convert. Low pH is
still required to activate the φ-clamp to a more closed state. Supporting this idea,
the pH gradient had a different effect on the PA pores prior to LFN introduction;
namely, the pores alone had a smaller current passing through it with pH gradient
than without the gradient (Figure 3.3, points C-F or EMT∆pH=0 versus EMT∆pH=3).
Previous reports had suggested that the structure of LFN or the structure of the φclamp within PA pore might be altered by pH environment.9,10,29 Specifically, the
loop possess residue (F427) of the φ-clamp in the PA pore may switch between
two conformations.25,43 This loop is also interpreted as pH sensor since mutation
on Asn422 or Asp425 in this loop abolished the pre-pore to pore conversion,
which should be triggered at low pH.112 Recently, two open states of the PA pore
caused from dilation at the φ-clamp have been resolved by the single-channel
electrophysiological recording.110 Importantly, these two conductance states were
better resolved at higher pH, suggesting a potential correlation between the φclamp dilation and the surrounding pH. Our result here clearly demonstrate that
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empty PA pore has a higher current state at ∆pH = 0 (pHcis 8.5, pHtrans 8.5) than at
∆pH = 3 (pHcis 5.5, pHtrans 8.5), suggesting that the conformational change of the
φ-clamp is highly dependent on its exposure to the surrounding pH. Therefore, we
propose that the conformational switches of the φ-clamp between two states may
occur during translocation due to protonation/deprotonation cycles of the
translocating peptide, which would likely generate local pH changes around the φclamp.

4.3.3 Pauses and Re-initiations of Anthrax translocation
Central tenants of the Brownian ratchet translocation model include that a
pH gradient is required throughout the translocation process of the entire cargo
and that the cargo cannot be retro-translocated once it enters the ratchet.10,30 We
hypothesized that if the gradient is abolished when LFN is only partially
translocated, the peptide would remain in the pores indefinitely. The average
translocation half-time of LFN is ~22 s in our device when ∆pH = 3, yet our device
can exchange the dome volume in approximately 1 second. Thus, it is possible to
change ∆pH = 3 to ∆pH = 0 far faster than the translocation time. In this section,
we switched pH gradient on (∆pH = 3) and off (∆pH = 0) during anthrax
translocation to intentionally trap LFN in the pore and verify our hypothesis.

4.3.3.1

A single pause and re-initiation of translocation

We created a DIB with approximately 3000 PA pores, loaded them with
LFN, performed a control translocation and noted nominal activity (Figure 4.2,
control region). Following reloading with LFN, the pores were subjected to ∆pH = 3
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for 13 seconds (Figure 4.2, indicated as ∆pH applied). After the typical pore block
was observed, the aqueous dome was perfused such that ∆pH = 0 and held for 3
min (Figure 4.2, indicated as ∆pH abolished). A rapid increase in current was first
observed, followed by a more stable current with slight increase. While the origin
of this rapid current increase at the beginning was of interest, it resembled the
difference between current level EMT∆pH=3 and EMT∆pH=0 of the empty pores in
some measure. Importantly, after the rapid increase, the current did not reach the
preloaded state PL∆pH=0. We surmise that PL∆pH=0 represents a preloaded state
where the LFN molecules are outside the ratchet mechanism but close enough to
block half the open pore current at pH 8.5. However, after translocation initiation,
the preloaded state converts to a loaded state where the LFN is inside the ratchet.
This rapid increase is hence not likely due to the backsliding of LF N peptide to the
top of the pores since the current after the rapid increase did not exceed PL ∆pH=0.
Also, as this rapid increase is much faster than the detachment current we
observed in Figure 4.1 (Figure 4.1, points B-C), we do not attribute this rapid
increase to LFN peptides detaching. Therefore, this rapid increase is likely
contributed from conformation changes of either or both proteins from a fully
blocked state to a less blocked state. During the following 3 min, the current was
much more stable and did not exceed PL∆pH=0, suggesting that once LFN entered
the ratchet, it neither drew back to the top of pore as the preloaded state nor slid
forward to complete the translocation without the ∆pH. The slight increase at this
stage was attributed to the release of PA-bound (though not yet threaded into the
ratchet) LFN, similar to our prior experiment (Figure 4.1, points B-C). The pH
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gradient was re-established by perfusig pH 5.5 buffer into the aqueous dome
(Figure 4.2, indicated as ∆pH reapplied). We note that a faster translocation
resumed until completion, which corresponded with our expectation since there
were less peptides remained in the protein due to LFN detachment over the 3minutes pause and a small fraction of translocation before the ∆pH was abolished.
To the best of our knowledge, this is the first demonstration of a translocation
pause and restart. This data suggest that once the pH gradient was removed, no
other existing forces were sufficient to complete LFN translocation. Thus, the pH
gradient was the only driving force required throughout the translocation in our
experiments. Also, the backsliding of LFN did not occur even without the pH
gradient, corresponding with the ratchet mechanism.
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Figure 4.2 Creating a “trapped” ratchet state with slight dissociation of LFN
from PA top. (N > 10) A voltage of –20 mV was applied throughout the recording.
A full translocation of LFN was performed as control. Next, the pores were
reloaded with LFN. Following the application of a ∆pH = 3 for about 13 s, the
gradient was abolished. The rapid increase upon abolishing ∆pH did not reach the
preloaded state (PL∆pH =0), suggesting that the peptide already entered the ratchet
did not backslide to the PA top. Over the next 3 minutes, little change in current
was observed due to the dissociation of LFN that has not yet entered the ratchet
from the top of the PA pore. The ∆pH was then reapplied, and translocation
proceeded to completion.

4.3.3.2

Iterative activation of pH-activated translocation

The results presented in Figure 4.2 demonstrate that LFN translocation can
be paused immediately after the application of a brief pH gradient to induce LFN
loading into the PA63 pore. According to the Brownian ratchet model, the
translocating peptides are continually protonated at the endosomal side as they
are unfolded and deprotonated at the cytosol side throughout the translocation.
That is, pH gradient is required throughout the translocation. We then wondered
whether the ability to pause depended on the degree of translocation. Therefore,
we conducted a translocation experiment using multiple rounds of starts and
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pauses (Figure 4.3a, points A-L). In all but the first cycle, the current in the paused
state (in blue) was flat, suggesting a stable system in the absence of a pH gradient.
During the first pause, there was a slight increase in current prior to the next reinitiation of translocation. As what we noted in Figure 4.2, we attribute this to the
detachment of LFN from the top of the PA pore as we observed in Figure 4.1.
Similar to Figure 4.2, we note that the current level at point B is lower than
PL∆pH=0 (Figure 4.3a), suggesting that LFN did not leave the ratchet. Furthermore,
the translocation curve at ∆pH = 3 was always re-established to the similar degree
as where it was paused (for example, Figure 4.3a, point E and point H), indicating
little amount of LFN was detached. This results presented in Figure 4.3a clearly
show that the translocation can be started and stopped at any point of the
translocation curve and supports the Brownian ratchet model.
The rapid change in current upon each switch of ∆pH emerged from the
iterative start-pause experiment as a noteworthy feature (Figure 4.3a). We note
that the current of ∆pH = 0 was higher than ∆pH = 3 in a nearly constant degree at
any point of the translocation (Figure 4.3a, points E-F and M-N). From the ∆pH
effect on the current through empty PA pores, we have suggested that the pore
may undergo conformational changes in response to its surrounding pH. However,
if the higher current at ∆pH = 0 was merely contributed from the same
conformational changes as we observed from the empty pores, the changes in
current between ∆pH = 0 and ∆pH = 3 should not be in a constant degree during
the translocation. Instead, when most of the pores were still occupied with LFN
peptides upon setting the ∆pH to zero, the increase in current should be less since
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the threaded peptides should have blocked the current to some degree. Therefore,
we suggest another type of conformational changes occurs to the LFN-threaded
pore in response to the change in ∆pH.
To interpret this rapid change in current, we consider two levels for current
normalization: the current observed when all of the pores were empty at ∆pH = 0
(EMT∆pH=0) and at ∆pH = 3 (EMT∆pH=3). We use the current from 55-75 s in Figure
4.3a to demonstrate the conformational change between the ∆pH states. (Figure
4.3b) The current at each ∆pH state was recalculated to its respect EMT.
Importantly, we consider that all current at ∆pH = 3 comes from empty pores. That
is, we do not expect partial block state at ∆pH = 3 since any LFN attached on pore
top would be driven into the pore by ∆pH and completely block the current once
the previous peptide has been translocated. In other words, percentage of
EMT∆pH=3 represented the population of empty pores at ∆pH = 3. For example, at
the third iteration of ratchet activation (Figure 4.3b, point H), the percentage of
EMT∆pH=3 was roughly 22%, indicating that the population of empty pores was
22%. Here, a particularly important feature emerged. During the pause
immediately preceding that point where ∆pH = 0 (Figure 4.3b, points F-G), the
percentage of EMT∆pH=0 was nearly 50%, indicating that the current here was 50%
of that under the condition when all pores were empty at ∆pH = 0. Since only 22%
of the pores were empty and contribute to the percentage, the remaining 28%
current must be contributed from LFN-threaded pores. The EMT percentage
analysis of the full trace (Figure 4.4) shows that after the initiation of
translocation, the current at ∆pH =3 had a remarkable lower EMT percentage than
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that at ∆pH =0. This difference diminished as the translocation proceeded until
both current reached 100% EMT. This result suggests that when ∆pH = 0, PA pores
with threaded LFN were not completely blocked and conducted ionic current.
Moreover, percentage of EMT profiles the states of LFN-threaded pores unaffected
by the differences of EMT∆pH=0 and EMT∆pH=3, whether or not it was contributed
from the conformation changes of empty pores. Therefore, the conformational
change of LFN-threaded pores is likely due to the LFN peptide switching between a
bulkier state and a less structured state, for example, between a helix and a
random coil.
In section 3.3.2 and 4.3.1, we attributed the current difference of the open
pores under different pH conditions to the conformational change of the φ-clamp.
Here in this section, Further evidence of conformational changes was found when
the translocation was iteratively paused and re-activated (Figure 4.3a). When the
ionic current at ∆pH = 0 and at ∆pH = 3 were compare in the percentages of
respective EMT, which represents the current observed when all of the pores were
empty, a higher percentage of EMT was observed at ∆pH = 0 (Figure 4.3b). It is
important to clarify here that since the percentage of EMT represents the blocking
degree of a pore relative to its empty state at the same pH condition, the difference
of the current through empty pores at different pH conditions (a.k.a. the difference
between EMT∆pH=0 and EMT∆pH=3) does not account for the difference between the
percentage of EMT at the two pH conditions. In other words, the conformational
change of the pore (or the φ-clamp) does not account for the higher percentage of
EMT when the translocation was abolished by ∆pH = 0. Moreover, it is unlikely
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that retro-translocation of the peptide strand after it enters the φ-clamp occurs, as
the current did not exceed the LFN-preloaded state when the ∆pH was abolished
(Figure 4.2). Therefore, the higher percentage of EMT at ∆pH = 0 was most likely
caused by ionic current leaking through LFN-threaded PA pore due to the
conformational change of the LFN, which should be tightly gripped and block any
current out at ∆pH = 3.
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Figure 4.3 a. Reiteration of trapped ratchet states. (N > 3) A voltage of –20 mV
was applied throughout the recording. Following loading LFN to the PA pores and
initiating the translocation, twelve switches of pH gradient were performed before
the translocation completed. Points A-L: pH 5.5 (∆pH = 3, red) or pH 8.5 (∆pH = 0,
blue) buffer was introduced for 5-10 s between each adjacent point. Point L: ∆pH =
3 was reapplied until the translocation proceeded to completion. After point M:
∆pH = 0 and ∆pH = 3 were applied respectively. The fully blocked state (FB∆pH =3),
LFN preloaded state (PL∆pH =0) and the current levels of empty pores (EMT∆pH =0
and EMT∆pH =3) were indicated in the right panel. b. Demonstration of current
percentages relative to empty pores at the paused state. The current in Fig.
4.3a from 55 s to 75 s was enlarged for analysis. When all of the pores on the DIB
membrane were empty, the current through these pores in both pH conditions
(EMT∆pH =0 and EMT∆pH =3) were fixed as 100%. At point E and point H, 22% of the
current was observed relative EMT∆pH =3, indicating a population of empty pores
of 22% since the pore is fully blocked with threaded LFN at ∆pH = 3. However,
during the pause immediately preceding point E where ∆pH = 0 (points F-G), the
percentage of EMT was nearly 50%, indicating that the current here was 50% of
that under the condition when all pores were empty at ∆pH = 0. Note that current
between points F-G was smaller than PL∆pH =0, suggesting no backsliding of the
peptides. Since only 22% of the pores were empty and contribute to the
percentage, the remaining 28% current must contributed from LFN-threaded
pores. A full-trace percentage analysis is in Figure 4.4.
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Figure 4.4 Complete current percentages analysis of translocation pauses
and re-initiations. a. Current recording of reiteration of trapped ratchet states
(Figure 4.3a). b. The current of the trace in the upper panel under ∆pH = 0 and
∆pH = 3 was normalized by EMT∆pH=0 and EMT∆pH=3, respectively, and the trace
was replotted as a function of the percentage of EMT versus time. That is, the
current percentage of the pause states (cyan and blue) were plotted relative to
EMT∆pH =0 (current level at ∆pH =0 when all pores were empty), and the current
percentage of the translocation states (orange and red) were plotted relative to
EMT∆pH =3 (current level at ∆pH =3 when all pores were empty). Data of the rapid
change in current upon each switch in pH was omitted in the graph (for example,
the current between points E-F). Overall, after the initiation of translocation, the
current at ∆pH =3 had a remarkable lower percentage than that at ∆pH =0. As the
translocation proceeded through each iteration, the percentages of EMT
converged at 100% empty pores. In order to fix the EMT both before loading LFN
and after translocation to 100%, the whole current was fitted to exponential decay
as normalization due to a slight drift in current.
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4.3.3.3

Iterative activation under salt asymmetry

The conformational change we observed in previous section was also
reflected in the experiment when an additional salt gradient was added to DIB at
∆pH = 3. (Figure 4.5) Recall that in previous experiments, the current through PA
open pores is smaller when ∆pH = 0 and larger when ∆pH = 3. (Figure 4.3a, where
EMT∆pH=3 was smaller than EMT∆pH=0) We suggest that conformational change of
PA pore accounts for this difference. Here we forced the ionic current through the
narrower PA pore at ∆pH = 3 to increase to the extent that it surpass the ionic
current through the pore at ∆pH = 0 by introducing an additional salt gradient to
the DIB when ∆pH = 3. We doubled the salt (KCl) concentration in pH 5.5 buffer
while maintain it the same in pH 8.5 buffer. ([KCl]pH5.5 = 200 mM and [KCl]pH8.5 =
100 mM) When ∆pH = 0, there was no salt gradient across the membrane; when
∆pH = 3, an additional KCl gradient existed as pH 5.5 buffer was perfused to the
grounded compartment of DIB while the top droplet of DIB remain pH 8.5. By this
method, we were able to reverse the effect of pH on the ionic current through
empty PA pores. That is, the current through empty PA pore at ∆pH = 3 in this
experiment is higher than ∆pH = 0. (Figure 4.5, in which EMT∆pH=0 was smaller
than EMT∆pH=3) The conformational changes were clearly observed after LFN
entered the φ-clamp. When the pH gradient was abolished after the initiation of
translocation, the current was higher at ∆pH = 0 than at ∆pH = 3 (Figure 4.5, points
B-E), which is opposite to the current before introducing LFN. As the translocation
proceeded and there were less and less LFN-threaded pores, the current levels of
the two pH states approached each other and then reversed back until they
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reached the initial levels. (Figure 4.5, points C-L) Upon each re-application of ∆pH
= 3, a sharp increase in current was instantly shown, probably caused by the
instant presence of salt gradient. Following the sharp increase, the later blockade
in current was likely due to the protonation of the proteins at pH 5.5, which led to
the conformational change within the LFN-threaded pore so that it became more
compact. The translocation then proceeded under ∆pH and the current slowly
opened. When more and more pores were free of LFN, the blockade became
smaller since there were less LFN-threaded pores contribute to the conformational
change.
The opposite effects of pH on the current in the middle of translocation
indicates that LFN blocks PA pore in a much smaller degree at ∆pH = 0 such that
the difference between EMT∆pH=0 and EMT∆pH=3, no matter which one was higher,
did not affect the higher current observed at ∆pH = 0 during translocation.
Therefore, even we have attributed the difference between EMT∆pH=0 and
EMT∆pH=3 to the conformational changes of the φ-clamp, there must be another
different type of conformational changes in LFN-threaded protein complex in
response to the different pH, corresponding with our conclusion in section 4.3.3.2.
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Figure 4.5 Current changes during translocation when ∆pH was
accompanied with an extra salt gradient. (N > 3) A voltage of –20 mV was
applied throughout the recording. The concentration of KCl in pH 5.5 buffer was
200 mM and in pH 8.5 buffer was 100 mM. The top droplet remained pH 8.5 with
[KCl] = 100 mM. Therefore, a ∆[KCl] = 100 mM existed when pH 5.5 was
introduced to the dome (∆pH = 3). The current level of EMT∆pH =3 is higher than
EMT∆pH =0, which is opposite to the experiment without salt gradient. Before point
I, pH 5.5 (∆pH = 3, red) or pH 8.5 (∆pH = 0, blue) was introduced to DIB for 3−9 s
between each adjacent point. Point I: ∆pH = 3 was reapplied until the translocation
proceeded to completion.

4.3.4 Jamming the ratchet mechanism by a hairpin-like LFN mutant
To confirm that the conformational changes of LFN peptides contribute to
the increase in conductance of LFN-threaded pores at pH 8.5, we aim at observing
the blocked while translocation-active state of the proteins. Using LFN, it was not
possible to achieve a blocked state of the pores under different pH conditions
without also translocating the peptide. Therefore, we used an LFN mutant with a
25-residue hairpin-like disulfide loop appended at its C-terminus, termed LFNC8C.
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The loop at the C-terminus is too large to pass through the φ-clamp and should
therefore jam the ratchet when engaged.43 We did not use a covalent bond
prenucleates helix since the less structured nature of the disulfide loop may allow
minute residual current through the jammed pores to be observed. Also, the
ratchet activity can be reassured by cleaving the disulfide bond after jamming the
ratchet. We first conducted a control experiment with conventional LFN to
demonstrate nominal translocation activity (Figure 4.6, control). Next, we
introduced the hairpin peptide at a pH of 5.5 (Figure 4.6, points A-B). The LFNC8C
sample was a mixture of oxidized and reduced hairpins, therefore a certain
fraction of the mutant peptide is able to translocate. By overwhelming the pores
with this mixture during the pH gradient application, we ensured that every pore
would eventually fill with an intact hairpin. Here, we observed that the ionic
current rapidly decayed to zero as the hairpins jammed the pores. When excess
LFN hairpin mutants were rinsed away with pH 5.5 buffer, most pores remained
blocked (Figure 4.6, points B-C). We note that when excess LFNC8C is rinsed away,
there is a very slight increase in ionic current as we cycle the pH between ∆pH = 3
and ∆pH = 0 conditions with a higher current at ∆pH = 0. (Figure 4.6, points B-E).
Since the hairpin is appended at the C-terminus of LFN, it jams the pore after the Nterminal LFN has passed through the φ-clamp. Hence, the increase in current is
unlikely die to the detachment or the retro-translocation of the peptide. Moreover,
when conventional LFN was reloaded after this slight increase in current, the
nominal translocation was observed (Figure 4.7), suggesting that the current
observed after loading LFNC8C was contributed from empty pores. Therefore, we
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attribute this increase to some form of very slow translocation relative to
conventional LFN. For example, the disulfide bond of jammed hairpins may
spontaneously hydrolyze at pH 8.5 at a slow rate followed by rapid translocation
to yield very few fully open pores. Alternatively, intact hairpins might translocate
very slowly with the flexibility of the φ-clamp.106 In either case, the remaining
jammed pores appear to be permanently blocked since the current only reached
~10% of EMT at both ∆pH, which was much smaller than the total current flows
through occupied pores even at ∆pH = 0 when using wt LFN (Compare to Figure
4.4b, points B-C). Therefore, it appears that pores were blocked by the hairpin to a
much greater degree at ∆pH = 0 compared to wt LFN.

75

Figure 4.6 Jamming the ratchet with a hairpin peptide. (N > 3) A voltage of –10
mV was applied throughout the recording. First, a full translocation of LFN was
performed as control. Points A-B: A mutant LFN with a hairpin-like peptide
appended on its C-terminus (LFNC8C) was introduced to DIB at pH 5.5. The pore
reached a fully blocked state within 30 s. The peptide was perfused for additional
50 s in order to translocate reduced linear LFNC8C and to block all of the pores.
Points B-C: pH 5.5 buffer was perfused for 30 s. A subtle increase in current was
observed. Points C-D: pH 8.5 buffer was perfused for 15 s. A slightly higher current
was shown. After point D: When different buffers were introduced, small change in
current was shown while most of the current was completely blocked.
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Figure 4.7 Wild-type LFN translocation through unjammed PA pores. (N = 2) A
voltage of –10 mV was applied throughout the recording. LFNC8C was introduced
to DIB in pH 5.5 and blocked the pore. Points A-B: Proteins were rinsed with pH
5.5 buffer (∆pH = 3). The current increased slightly and slowly. Points B-C: pH 8.5
buffer was introduced (∆pH = 0) with a higher current observed. Points C-D: The
current was stable but responded differently to different pH conditions. Points DE: Wild-type LFN was introduced and the partially block state was observed. After
point E: pH 5.5 buffer was introduced (∆pH = 3) and a conventional translocation
curve of LFN was observed.

We conducted a separate jamming experiment to see whether the proteins
were still functional after introducing the hairpin (Figure 4.8). In this case, LFNC8C
was introduced at pH 8.5 and then forced into the ratchet using a pH gradient
(Figure 4.8, A-B, B-C). The pores were blocked to a greater extent than
immediately preceding control experiment with LFN, but were less blocked than
when introducing the hairpin at pH. 5.5 (Figure 4.6). Following two pH cycles, we
were left with a mixture of fully open pores and hairpin-jammed pores. Further
translocation of hairpin was enabled by addition of TCEP to cleave some of the
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disulfide bonds. The cleavage was relatively poor; even after 4 minutes incubation,
only a slight increase in current was observed following a pH 5.5 rinse. However,
the characteristic current reduction and translocate was recorded (Figure 4.8, GH), showing that the pores were still functional. These results suggest that the
hairpin is relatively inaccessible by TCEP and therefore likely remains jammed
deep in the φ-clamp even when ∆pH = 0. Following this, wt LFN could be
introduced and translocated on the non-hairpin-occupied population of pores with
nominal translocation observed (Figure 4.8, points I−J), suggesting that the hairpin
did not permanently deactivate the ratchet.

78

Figure 4.8 The pore function was not perturbed with LFNC8C. (N > 3) A voltage
of –10 mV was applied throughout the recording. A full translocation was
performed as control prior to the pore jamming. Points A-B: LFNC8C was
introduced in pH 8.5, the partial block state was observed. Points B-C: pH 5.5 was
introduced. Some translocation was observed due to a portion of reduced hairpin.
Points C-D: pH 8.5 was introduced with a higher current observed. Points D-E: The
current was stable yet responded differently to different pH conditions. Points E-F:
10 mM TCEP was introduced to DIB in pH 8.5 for 45 s, then DIB was incubated
with TCEP for 3 minutes to reduce the disulfide bond appended at LFNC8C. When
TCEP was reintroduced to DIB twice (for 17 and 25 s) after the incubation, no
additional change in conductance was observed, suggesting that the disulfide bond
may be relatively inaccessible by TCEP. Points F-G: TCEP was rinsed away by pH
8.5. Points G-H: pH 5.5 was introduced and a translocation curve of linearized
LFNC8C was observed. Points H-I: The current was stable and responded
differently to different pH conditions. Points I-J: A full translocation of wt LFN was
performed to verify PA pore function.

In section 4.3.3.2 and 4.3.3.3, we have suggested a different type of
conformational changes in LFN-threaded protein complex other than the φ-clamp
dilation in response to the different pH. When we jammed PA pores with hairpinlike LFN mutants (LFNC8C) in this section, the pores were blocked to a much
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greater degree at ∆pH = 0 than using wt LFN. Therefore, we suggest that at the
jammed state, the disulfide loop is directly engaged with the φ-clamp and
completely blocked the pore at both ∆pH. In other words, changing the shape of
the peptide from linear to bulky caused a greater decrease in current than
changing ∆pH = 0 to ∆pH = 3 alone. This further provides evidence for the
conformational change of the translocating wt LFN upon switching the ∆pH to zero.
Since the current increased substantially at ∆pH = 0 in the middle of wt LFN
translocation (Figure 4.3, B-C), LFN peptide must has switched to a less bulky form
from ∆pH = 3 to ∆pH = 0. This corresponds with the perspective of allosteric helix
compression model, which composed of a putative mechanism of substrate
peptide coil-to-helix/helix-to-coil cycles.110,111 Our results suggest that the
substrate may undergo a reversible coil-to-helix compression process at the
endosomal side as it unfolds at low pH and enters the pore.

4.4 Conclusion
In this work, our technique of DIB perfusion system enables us to monitor
the protein translocation across membrane under a variety of controls. While LFN
could be detached from PA pore before the initiation of translocation, we showed
that translocation ceases as soon as the pH gradient is removed after LFN enters
the φ-clamp. The fact that anthrax translocation can be iteratively activated in
vitro simply by cycling the pH gradient provides perhaps the strongest evidence
yet for a Brownian ratchet model of protein translocation through a pore.
Moreover, pauses/re-initiations of wt LFN translocation and mutant LFNC8C-
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jammed pores revealed that there are conformational changes occur to the toxins.
From our data, it revealed that conformational changes occur both to the φ-clamp
within the PA pore and the translocating peptide when the translocation is
interrupted by pH environment. When the pH gradient is present, LFN and the φclamp compress tightly; when the pH gradient is removed, LFN becomes less bulky
and the φ-clamp relaxes from its tightly griping form so that leaking current can
pass through LFN-threaded pores. Overall, from our work on anthrax
translocation, it provides insights into the interactions between substrate and
membrane pore by which the substrate is translocated into the cytosol using
proton gradient.
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CHAPTER 5
SMALL MOLECULES THAT MIGHT BLOCK PROTECTIVE ANTIGEN

5.1 Overview
In order to seek for an effective therapeutic strategy for anthrax infection,
several inhibitors that block protective antigen (PA) pore and prevent lethal factor
(LF) and edema factor (EF) translocate across membrane have been designed
either through peptide selection with phage display or through inspiration from
the blockers of other heptameric membrane pores.82,84,113,114 In this chapter, two
small molecules that are commonly used for biological buffers, glycine and TAPS
(3-{[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]amino}propane-1-sulfonic
acid), show the possibilities of blocking PA pores and would therefore interfere
electrophysiology recordings for anthrax activity. We used the droplet-interface
bilayer (DIB)-based flow chip described in Chapter 3 to demonstrate how PA
pores react to buffers made with these two molecules differently than to the buffer
made

with

Tris

(2-Amino-2-(hydroxymethyl)propane-1,3-diol),

another

commonly used buffer salt. Our results provide not only the information of
undesirable conditions that we suggest to avoid in studying anthrax translocation,
but also insights into strategies for disabling the toxin from perspective of
structure-based drug design.
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5.2 Materials and Methods
5.2.1 Proteins and Chemicals
Both recombinant wild-type PA heptameric pre-pore and LFN expressed
and purified as described11,14,87 were generous gifts from both Dr R. J. Collier
(Harvard Medical School) and Dr. B. A. Krantz (University of Maryland Baltimore).
PA pre-pore was diluted in pH 8.5 buffer (10 mM MES, 10 mM Tris, 100 mM KCl,
pH 8.5) to a final concentration of ~7 ng/μl for the perfusion system.

5.2.2 Preparation of DIB-based flow chip
The general preparation of DIB-based flow chip has been described in
section 3.2.2. In this Chapter, besides the PA pre-pore solution (~7 ng/μl in 10 mM
MES, 10 mM Tris, 100 mM KCl, pH 8.5), three sets of buffers with MES and three
different basic buffer salts and were prepared for perfusion: Two Tris buffers (10
mM MES, 10 mM Tris, 100 mM KCl, pH 8.5 and pH 5.5), two glycine buffers (10 mM
MES, 10 mM glycine, 100 mM KCl, pH 8.5 and pH 5.5) and two TAPS buffers (10
mM MES, 10 mM TAPS, 100 mM KCl, pH 8.5 and pH 5.5). Hexadecane was added
on the top after introducing aqueous solutions in the flow chip.

5.2.3 DIB preparation, electrophysiology and operation of the flow chip
DIB preparation and electrophysiology recording method were the same as
those described in section 3.2.3 Operation of the flow chip has been described in
section 3.3.1
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5.3 Results and Discussion
Glycine (pKa1 (25 °C) = 2.3; pKa2 (25 °C) = 9.8) and TAPS (pKa (25 °C) =
8.4) have been widely used in biological buffers. However, we have found these
two small molecules might interact with PA pore and hinder proper
electrophysiology recording of its function. Here, the ionic current passing through
PA pores in the presence of buffers made from glycine (10 mM MES, 10 mM
glycine, 100 mM KCl, pH 8.5 or pH 5.5, “glycine buffer”) or TAPS (10 mM MES, 10
mM TAPS, 100 mM KCl, pH 8.5 or pH 5.5, “TAPS buffer”) was compared with that
in the presence of the buffer made from Tris (10 mM MES, 10 mM Tris, 100 mM
KCl, pH 8.5 or pH 5.5, “Tris buffer”).

5.3.1 Glycine decreases ionic current passing through PA pores
We created a DIB on the flow chip and perfused glycine buffers to the
bottom dome of the DIB with the top droplet remained constant with vesicle made
from pH 8.5 glycine buffer. (Figure 3.1a) After PA pre-pores were introduced to
the dome in pH 8.5, insertion of the pores was triggered by applying pH 5.5 glycine
buffer. (Figure 5.1, point A) However, unlike we observed in other experiments
using Tris buffers (Figure 3.3), the ionic current decreased instead of reaching a
steady level the insertion of PA pores. When we applied an external triangle wave
voltage to measure the bilayer size via conductance method,88 it was shown that
the bilayer size did not alter during the decrease in current. As we perfused pH 8.5
to the pores, an increase in current was observed followed by a continuous
decrease. (Figure 5.1, point B) We suspect that glycine interacts with PA pores and
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reduces the size of the pore hollow in both pH conditions. When PA was exposed
to pH 8.5, the conformational change might have led to the initial increase in
current as we discussed in Chapter 4. However, the interaction of the glycine and
the PA pores might further reduce the diameter within the pore and therefore
result in a decrease in ionic current. In order to study if this effect is reversible, we
perfused the Tris buffers and glycine buffers in turns to PA pores. (Figure 5.2)
Here, the top droplet used vesicle solution made from pH 8.5 Tris buffer so that
the effect of glycine, if any, could be excluded from the droplet side. After PA pores
were inserted by pH 5.5 glycine buffer and the ionic current decreased for ~1.5
minutes, Tris buffers were perfused to the DIB and a rapid increase in current was
observed. (Figure 5.2a, point B) The current reached a steady state, as it usually
did when glycine buffers were not introduced. As the glycine buffers were again
introduced, a rapid decrease of more than 85% in current was observed either in
pH 8.5 or pH 5.5. (Figure 5.2a, point E and Figure 5.2b, point B) If pH 8.5 glycine
buffer was introduced to DIB following pH 5.5 glycine buffer without a rinse of
Tris buffer in between, the current slightly increased and then decreased slowly,
similar to point B in Figure 5.1. (Data not shown) It is still unclear why glycine
reduced the current slower before rinses with Tris buffers. However, glycine has
been previously reported as a stabilizer that prevents the thermal inactivation of
PA, suggesting a weak interaction between PA and glycine. 115 We thus surmise
that glycine might have weak binding with PA pore that leads to current blocking
in the pores. When glycine buffers were used, we found that LFN could still be
translocated through PA pores. However, the electrophysiology recording of the
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ionic current was difficult to be interpreted due to the mixed signal from
translocation and glycine binding.

Figure 5.1 The ionic current slowly changed with glycine buffer. The bars on
the top indicate different buffers perfused through the grounded dome of the DIB
flow chip (Fig. 3.1) with the top droplet remains constant with pH 8.5 glycine
buffer. A voltage of –20 mV was clamped throughout the recording. PA pre-pores
were introduced to DIB in pH 8.5 glycine buffer before point A. A: Insertion of PA
pores was triggered by perfusing pH 5.5 to DIB. However, the ionic current slowly
decreased after the insertion. B: Rinse the pore with pH 8.5. The ionic current first
slowly increased and then decreased. A triangle wave with 2.5 mV amplitude and
100 Hz frequency was applied to monitor the bilayer size using capacitance
method.88 It was shown that the bilayer size did not change when the current
decreased.
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Figure 5.2 Glycine buffers reduced the ionic current through PA pores.
Different buffers were perfused through the grounded dome of the DIB flow chip
with the top droplet remains constant with pH 8.5 Tris buffer. A voltage of –20 mV
was clamped throughout both recordings. a. PA pre-pores were introduced to DIB
in pH 8.5 Tris buffer before point A. A: Insertion of PA pores was triggered by
perfusing pH 5.5 glycine buffer to DIB. However, the ionic current slowly
decreased after the insertion. B: Rinse the pore with pH 5.5 Tris buffer. Ionic
current rapidly increased and became stable. C: Rinse the pore with pH 8.5 Tris
buffer. D: Rinse the pore with pH 5.5 Tris buffer. E: Rinse the pore with pH 8.5
glycine buffer. The conductance decreased about 85%. F: Rinse the pore with pH
5.5 Tris buffer. b. Approximate 1500 PA pores were on the DIB. A: pH 8.5 Tris
buffer was applied to DIB. B: pH 5.5 glycine buffer was applied to DIB. The
conductance decreased about 85%. C: pH 5.5 Tris buffer was applied. D: pH 8.5
Tris buffer was applied. E: pH 8.5 glycine buffer was introduced to DIB.
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5.3.2 TAPS does not provide ideal electrophysiology environment for
studying anthrax translocation
When we used TAPS buffers to treat PA pores on DIB, we observed similar
decrease in current at pH 5.5 as we observed when using glycine buffers. However,
ionic current did not decrease in the pH 8.5 TAPS buffer. (Figure 5.3) Instead, it
increased slowly when pH 8.5 TAPS buffer was introduced to the membrane. It has
been reported that protonated aminosulfonate moiety on TAPS inhibits connexin
channel activity.116 We thus suspected that acidic TAPS also affect the function PA
pores. However, regardless the interference of the decreasing current at pH 5.5
and the slowly increasing current at pH 8.5, translocation of LFN was still able to
be performed with TAPS buffers. (Data not shown) Therefore, we suggest a weak
interaction between acidic TAPS and PA pores that can be reversed by a increase
in pH and does not affect the translocating function of the pore. Similar to previous
section, we next created a DIB on the flow chip with approximately 3000 PA pores,
and perfused Tris buffers or TAPS buffers to the bottom dome of DIB with the top
droplet remained constant with vesicle made from pH 8.5 Tris buffer. (Figure 5.4)
This is for understanding if the effect of TAPS on the pores could be rinsed away
by the Tris buffers. It was found that when TAPS was introduced to PA pore, the
ionic current rapidly decreased about 25% of the current from where Tris buffers
were perfused. This reduction in current was similar to the perfusion with glycine
buffers but not as much. Therefore, we suggest that the interactions between
acidic TAPS might be even weaker than the interaction between glycine and PA
pores. We noted that in Figure 5.4, the change in current with TAPS perfusion was
more rapidly than those in Figure 5.3. This was similar to what we observed when
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using glycine buffers (Figure 5.2) and needs further investigation. Nevertheless,
we assure here that TAPS might not be suitable as the buffering salts for studying
anthrax translocation by electrophysiology method since the drifts in current
largely hinder the current changes contributed from translocation.

Figure 5.3 The ionic current slowly changed with TAPS buffer. Different
buffers were perfused through the grounded dome of the DIB flow chip with the
top droplet remains constant with pH 8.5 TAPS buffer. A voltage of –20 mV was
clamped throughout the recording. PA pre-pores were introduced to DIB in pH 8.5
TAPS buffer before point A. A: Insertion of PA pores was triggered by perfusing pH
5.5 TAPS buffer to DIB. However, the ionic current slowly decreased after the
insertion. B: Rinse the pore with pH 8.5 TAPS buffer. The ionic current increased
slowly.
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Figure 5.4 TAPS reduced the ionic current through PA pores. Different buffers
were perfused through the grounded dome of the DIB flow chip with the top
droplet remains constant with pH 8.5 Tris buffer. A voltage of –20 mV was
clamped throughout the recording. About 3000 PA pores were introduced to the
membrane. A: pH 5.5 Tris buffer was introduced to DIB. B: pH 5.5 TAPS buffer was
introduced to DIB. The conductance decreased about 25%. C: pH 8.5 TAPS buffer
introduced to the membrane. D: pH 8.5 Tris buffer was introduced. E: pH 5.5 Tris
buffer was introduced to DIB. F: pH 8.5 TAPS buffer introduced to the membrane.
G: pH 8.5 Tris buffer was introduced.

5.4 Conclusion
In this chapter, we replaced Tris with glycine and TAPS as buffer salts used
in studying anthrax translocation. We found that after PA pore insertion, both
glycine and acidic TAPS buffers led to a decrease in current passing through the
pores. Comparing with the buffers made with Tris, a significant lower ionic current
was observed when buffers made with glycine or TAPS were introduced to the PA
pores. The decrease in current could be removed by perfusing buffers of Tris to
the pores. From our results, we suspect that glycine and protonated TAPS might
weakly bind to PA pore and affect the detection of pore function by ionic current.
Therefore, it is not encouraged to use these two small molecules in the studies of
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anthrax translocation using electrophysiology method. Further investigation will
be needed for investigating the current-blocking phenomena and might be able to
provide insights into structure-inspired drug design and strategies for disabling
anthrax toxin.
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CHAPTER 6
SUMMARY AND FUTURE OUTLOOK
Anthrax toxin has been used as an ideal proton gradient-driven protein
translocation model because of the accessibility and security reasons. On the other
hand, droplet-interface bilayer (DIB) has unique application and has become a
mature technique for lipid and membrane protein research in the past five years.
All of the preceding chapters in this dissertation are devoted to exploiting
advantages of DIB-based technique for studying mechanisms of anthrax
translocation and demonstrating the advances of our understanding towards the
mechanisms. This final chapter summarizes the discussion of results in each
chapter and speculates upon avenues for future work.
Electrochemical gradients across membrane commonly exist all over cells
and is the main driving force for protein translocation, including anthrax toxin. In
order to mimic cellular environment on DIB, it is important to understand if the
gradient across lipid bilayer can be conserved with low droplet volumes. In
Chapter 2, the stability of proton gradient across DIB was demonstrated. The
capability of DIB in studying lipid or membrane protein with the presence of
proton gradient was verified. This allows studies of protein translocations depend
on proton-motive force to be performed on DIB. Importantly, proton flux across
the pH-gradient membrane was observed when the buffering salts were fixed at
low concentration on purpose. Previously, proton flux has been studied on
different artificial lipid bilayer platforms and varies widely from one to another.67
As DIB has an unique advantage of creating lipid leaflet asymmetry, which is
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commonly exist in cellular membranes, it provides a promising platform for
understanding proton-hydroxide permeability of biological membranes. On the
other hand, pH-sensitive dye such as BCECF has been mostly used in the
measurement of intracellular pH. When BCECF acts as dual-excitation (or
ratiometric excitation) pH sensor, the measurement of pH can be independent of
dye concentration. Therefore, by combining DIB, Dimple chip and BCECF-dextran,
how electrochemical proton gradients play roles on different cellular membrane
types can be easily studied.
A variant on DIB-based technique called the flow chip was developed and
demonstrated in Chapter 3. The flow chip allows multiple, repeated or continuous
perfusions of different solutions to one side of a DIB. The flow chip maintains all of
the key advantages of DIBs, including low volumes, ability to create bilayer leaflet
asymmetry and to separate the monolayers at any point in an experiment.
Moreover, the bilayer of the flow chip is stable throughout the perfusions up to
hours. The sophisticated capability of the flow chip was demonstrated by protein
gradient-driven LFN (the N-terminus truncation of anthrax lethal factor)
translocation through the PA (protective antigen of anthrax toxin) pore and was
used for study mechanisms of the translocation in Chapter 4.
A proton-motive force, which results from a combination of membrane
potential and a pH gradient, is often required for protein translocations across
cellular membranes. Although conventional model membranes can easily control
membrane potential, it is laborious to control and switch pH gradient. The flow
chip allows pH gradient to be repeatedly changed at any point in an experiment. In
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the translocation of LFN, the pore status was distinctive between different pH
gradients. Our flow chip enables other studies such as those require changing
environment of the membrane or fast screening of the drug. For example, reagents
could be successively added and removed to rapidly screen their interactions with
proteins embedded in the lipid bilayer.
Although the flow chip is sophisticated enough for daily use, the cleaning,
assembly and operation are still relatively laborious due to its home-made feature.
Automation and mass-production of the platform will be an area that is worth to
invest. For example, the infusing and withdrawing pumps can be automated so
that systematic screenings can be performed by programmed perfusions.
In Chapter 4, we dive into the mechanisms of anthrax translocation using
the flow chip. We mainly used LFN as the substrate that translocate through PA
pore. Based on the Brownian ratchet model that describes anthrax translocation,
we hypothesized that LFN could only enter and be “clamped” by the φ-clamp
within the PA pore once the pH gradient is established. Moreover, we
hypothesized that if the pH gradient was abolished in the middle of translocation,
LFN would stay in the pore infinitely. Our results in Chapter 4 support these
hypotheses. We demonstrate that LFN peptide partially blocks PA pore once
attaches to it but can still be rinsed away from PA top before translocation is
initiated by establishing a pH gradient. When a pH gradient is applied, LFN is
driven into the φ-clamp, completely blocks the pore, and cannot slide back to the
substrate side. We demonstrated the first effort of pausing and restarting a
translocation by abolishing and re-applying the pH gradient to the membrane. This
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highly supports the Brownian ratchet translocation model, in which a proton
gradient is required throughout the whole translocation process until the peptide
is delivered to the other side.
It has been proposed that the φ-clamp or LFN peptide may switch their
conformation through the protonation/deprotonation cycles in Brownian ratchet
model.9,10,45 When the translocation was paused and restarted for multiple times
in our experiments, evidences of protein conformational change were emerged.
We noticed that when the pH gradient was abolished, ionic current could leak
through the LFN-threaded pore, which is completely blocked when the pH gradient
is presence. Based on our observations that the current through an empty pore at
zero gradient is less than with a gradient, we suggest that the φ-clamp of PA pore
may switch to a closer state under a pH gradient. However, when we employed a
mutant form of LFN with a hairpin-like tail that does not translocate, complete
block in current was found at zero gradient, indicating that bulkier conformation
of the substrate may also reduce the ionic current leaks through the pore.
Therefore, it is likely that both the φ-clamp and LFN peptide undergo
conformational change when the surrounding pH is altered.
Much has been learned about the translocation of LFN, but there are a
number of additional questions to answer and await further works. For example, it
has been proposed that multiple substrates may bind to and translocate through a
PA pore cooperatively.49,117 This could probably be resolved by analyzing the
detaching or translocation curve of substrates-saturated PA pores and the curve of
PA pores with controlled amount of substrates. Also, how pH environment alters
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the conformations of the φ-clamp and the substrate is still unclear. It is possible
that mutagenesis coupled with our flow chip will provide insights into this
question.
Chapter 5 outlines our efforts to seek ideal conditions in study anthrax
translocation and screen small molecules potentially block PA pores. We
demonstrates that glycine blocks the current passing through PA pore to the
extent that it is impossible to analyze electrophysiology recording of translocation.
TAPS also showed moderate current blocking mainly at low pH. Since glycine and
TAPS are commonly used in biological buffers, we suggest that they should be
avoided in studying anthrax translocation especially when using electrophysiology.
Although the decreases in current caused by both molecules do not seem to affect
the ability of pore to translocate, subsequent efforts could seek to further
understand the interactions of PA pore and these two molecules and will possibly
provide insights into drug design based on disabling PA pores.
Overall, this dissertation establishes a stable membrane perfusion platform
and promises a deep understanding of protein translocation driven by protonmotive force from perspective of anthrax translocation.
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